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The organisation o f the actin cytoskeleton within eukaryotic cells is controlled by a large 
variety of actin-binding proteins (ABPs) with roles ranging from nucléation to bundling, 
severing and capping of actin filaments. The calponins and transgelins are a family of 
actin-binding/bundling proteins possessing one or more highly conserved motifs (i) 
calponin homology (CH) domain, and (ii) calponin-like repeat (CLR/ CLIK23 repeat), 
which have both been implicated in acting-binding. The Saccharomyces cerevisiae gene |
SCPl encodes a protein, which shares a high degree of homology with SM22/transgelin.
■
In this study Scplp was purified and, using a range of biochemical techniques was shown 
to possess actin-bundling activity. Further analysis by EM revealed the formation of tight 
bundles of actin in the presence of Scplp.
Although a large number of protein containing CH domains have been shown to bind îIactin, the CH domain alone is not sufficient to bind actin. Using amino and carboxy 
terminal (N- and C-term) Scplp truncated mutants it has been possible to localise the 
actin-binding domain (ABD) to the C-terminal region containing the CLR/CLIK23 
repeat, and to show that the CH domain alone is not able to bind actin.
In vivo studies into the localisation of Scplp have revealed a co-localisation with actin to 
patches at the cell cortex. Other proteins found at these actin patches include the yeast 
flmbrin homologue Sac6p, another CH domain-containing protein involved in actin 
bundling. It has been shown that deletion of the SCPl gene alone has no adverse affect 
on actin organisation, whereas a SAC6/SCP1 double knockout displays a more defective 
actin phenotype than the SAC6 single knockout. The importance of Scplp in organising 
the actin cytoskeleton is clearly shown in cells overexpressing Scplp, which possess a 
severely disrupted actin cytoskeleton, with the appearance o f large clumpy actin patches.
Taken together this study shows that Scplp is an actin-bundling protein, which is 
involved with Sac6p in the organisation of the yeast cytoskeleton.
1. Introduction
1.1 The eukaryotic cytoskeleton
The components of the cytoskeleton and the proteins that help regulate it are highly 
conserved and make up a large amount of the total protein in eukaryotic cells. The 
cytoskeleton represents a three dimensional meshwork of interconnected proteins that (i) 
controls the shape of the cell, (ii) co-ordinates and drives the movement of the cell, and 
(iii) facilitates the intracellular movement of organelles and other proteins. It consists of 
three main filamentous networks:- (i) microtubules (ii) microfilaments, and (iii) 
intermediate filaments, with each being comprised of different proteins. These networks 
will be discussed in turn.
1.1.1 Microtubules
Microtubules are the largest of the three filaments and are made of tubulin, which is a 55 
kDa protein found as both a , and p forms. It actively forms heterodimers, and it is these 
which assemble in the presence of Mg^^ and GTP to form microtubules. These structures 
are made from parallel bundles of thirteen protofilaments and appear as hollow tubes 25 
nm in diameter. They exhibit polarised growth with one end being able to polymerise 
tubulin three times quicker than the other. Nucléation occurs at the centrosomes, which 
are the major microtubule organising centres (MTOC) in most animal cells and extend 
towards the cell periphery. Microtubule associated proteins (MAPs) such as dynein and 
kinesin utilise the microtubule network in the transport of organelles around the cell. It is 
worth noting that in Saccharomyces cerevisiae the role of intracellular transport falls on 
microfilaments, with microtubules being involved in the nuclear movement to the bud 
site and chromosome segregation.
1.1.2 Intermediate filaments
Intermediate filaments (IPs), which are not found in all cells types, are made up of a 
variety of different fibrous proteins, including keratins, desmin, nuclear lamins and 
vimentin. These proteins are rigid structures with a diameter of around 10 nm found 
mainly in cells that are under mechanical stress (eg epithelia, nerve axons) and are the 
most abundant proteins in skin and hair. The various proteins which can form IFs have 
similar domain organisation, namely an amino terminal head domain, a central a  helical 
rod domain and a carboxy terminal tail domain. They appear to be limited in function to 
one of providing tensile strength to certain cells and tissues, with relatively little being 
known about the diversity of the head and tail regions and their possible roles (Strelkov, 
Herrmann, & Aebi 2003)
1.1.3 Microfilaments
The third type of filaments are the microfilaments; these are made of the polymers of the 
43 kDa protein actin and appear as threadlike structures about 8 nm in diameter. 
Polymerisation of actin requires both monovalent and divalent cations as well as ATP. 
Microfilaments are highly dynamic structures and are regulated by a wide variety of 
actin-binding proteins. They help to provide shape to cells, and are connected to the 
cellular membranes by membrane microfilament-binding proteins. In most cells 
microfilaments exist as a dense mesh-like network below the plasma membrane called 
the cortex. Cellular locomotion occurs as a result of the polarised polymerisation of 
microfilaments at the leading edge of motile cells, and can be seen in the formation of 
filipodia, lamellipodia and membrane ruffles. It is also worth noting that in S. cerevisiae 
microfilaments confer polarity on the cell, with a rearrangement of their distribution 
occurring during the cell cycle.
1.2 Actin
Actin is one of the most abundant proteins found in eukaryotic cells, and can account for 
up to 5% of the total cellular protein in non-muscle cells. It is highly conserved
throughout all o f the eukaryotes with less than 20% difference in sequence being 
observed between mammalian and yeast actin. It is expressed from one gene in yeast 
(ACTl) and from up to 60 in some plants (Meagher 1991), with the human genome 
possessing six actin genes. In humans there are three different types of actin; a, P and 
Y with four alpha isoforms found in muscle cells and the P and y isoforms being found in 
non-muscle cells (Pollard, Blanchoin, & Mullins 2001). Actin is a globular protein (G- 
actin) in its monomeric form that polymerises to a filamentous form (F-actin) in a 
concentration-dependent manner.
Since all eukaryotic cells have an abundance of actin, with there being almost no 
difference in the structure of the actin isoforms it is intriguing that the actin cytoskeleton 
can play such diverse roles in different cell types. The answer to this problem lies in the 
large variety of actin-binding proteins (ABPs) that interact with different domains on the 
surface of the protein and act to control the occurrence or distribution of various actin 
structures within the cell’s complement of proteins, (dos Remedies et al. 2003;McGough 
1998; Otto 1994). Many of these ABPs are also controlled by a wide range of intracellular 
second messengers; resulting in a cytoskeleton that is highly dynamic in its re­
organisation in response to both internal and external stimuli.
It is also of note that although actin is absent in prokaryotic cells, its ancestry may lie in 
the protein MreB that has recently been shown to form filamentous structures located 
close to the cell surface o îBacillus subtilis (Jones, Carballido-Lopez, & Errington 2001). 
Although the amino acid sequence of MreB has only 15% identity with actin, the 
structure of its filaments is remarkably similar though it forms only single rather than 
paired helices (van den, Amos, & Lowe 2001).
1.2.1 G-actin
G-actin is a single polypeptide chain of 375 amino acids and a molecular weight of 43 
kDa; it was first predicted to exist as a pear-shaped molecule with a ‘large” and a “small’ 
domain (Aebi et al. 1981).
Although the first crystals of monomeric actin were reported over 20 years ago when it 
was co-crystallised with pancreatic DNAse 1 (Mannherz, Kabsch, & Leverman
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Figurel. 1 Actin Structure
(a.)Ribbon diagram showing G-actin in the ADP-bound state. It is comprised 
of 4 sub-domains labelled 1, 2, 3, and, 4; with a DNase 1 binding loop situated 
at the top of sub-domain 2. Four Ca^  ^ions are represented as gold spheres and 
can be seen bound to sub-domains 1,2, and 4, as well as in close proximity to 
the nucleotide binding cleft. Taken fi’om Otterbein et al 2001(b.)The “Holmes 
model” of an actin filament in which we can see six actin monomers 
exhibiting a % turn of a two start, right handed, long pitch helix. Taken from 
Dos Remedios et al 2003.
1977), it was not until 1990 that the structure was solved to a resolution of 2.4Â (Kabsch 
et al. 1990). Further modifications were made to this structure by the subsequent 
crystallisations firstly with gelsolin-1 (McLaughlin et al. 1993) and subsequently with 
profilin (Schutt et al. 1993). It was not until 2001 that crystals of monomeric actin not 
complexed with ABPs were produced (Otterbein, Graceffa, & Dominguez 2001).
These studies have revealed a structure with a large a-helical content (Fig. 1.1a) that can 
be divided into four sub-domains numbered 1, 2, 3, and, 4 with both the amino and 
carboxy termini located at sub-domain 2. These sub-domains surround a cleft which is 
occupied by ATP or ADP, the former binding with an affinity ten times greater than that 
of the latter, and in complex with either Mg^^ (Ka 1.2nM) or Ca^^ (Ka 0.12 nM). 
Conformational changes which can cause an opening and closing of this nucleotide 
binding cleft (Tirion et al. 1995) have been ascribed to a “hinge” at residues 140 and 338, 
with other changes in conformations occurring as a result of actin binding to different 
ABPs (Dedova et al. 2002).
1.2.2 F-actin
Although the atomic structure of F-actin has yet to be solved, it has been long been 
known to exhibit a helical nature (Hanson & Lowy 1964), with a more accepted model of 
it showing a two-start, right handed, long pitch helix (Holmes et al. 1990) (Fig. 1.1b) 
comprising 12-14 monomers per half turn. Further refinements to this model have been 
made using actin mutants (Lorenz, Popp, & Holmes 1993) and also by taking into 
account the hinge motion of the domains at the nucleotide-binding cleft (Tirion, ben 
Avraham, Lorenz, & Holmes 1995).
The polarity of F-actin can be seen in electron micrographs of actin filaments decorated 
with myosin sub-domain 1 (Lewis & Bridgman 1992). The myosin binds to the side of 
the filaments with a slight tilt and gives the appearance of arrowheads (Fig. 1.2) with 
their “pointed” ends aligning with sub-domains 2 & 4, and sub-domains 1 & 3 being 
represented by the “barbed” ends.
In vitro polymerisation of G-actin to F-actin occurs in three main stages (Oosawa et al. 
1977) and is promoted by high ionic strength and a slightly acidic or neutral pH
"  -I -.‘J t■■■ kr- ■■- • : .  -
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Figure 1.2 F-actin exhibits polarity
An electron micrograph showing myosin SI binding to actin filaments 
exhibits polarity and gives the appearance of arrow heads, with the 
pointed ends (p) representing sub-domains 2 and 4; and the barbed ends 
(b) representing sub-domains 1 and 3. Taken from Lewis and Bridgeman 
1992
(Greer & Schekman 1982a; 1982b). This transition is reversible with depolymerisation 
occurring when the ionic strength of the solution is lowered.
First there is the lag phase, which consists of a slow dimérisation step followed by the 
formation of a stable trimer known as the nucleus. Next follows a rapid elongation phase 
where G-actin can associate with both the barbed and pointed ends of filaments, although 
the former occurs at a rate 5-10 times faster than the latter The third phase, known as the 
steady state, occurs when G-actin monomers are exchanged at both ends with no resulting 
change in the length of the filament. (Fig. 1.3).
In vivo the majority of G-actin subunits contain ATP within their nucleotide binding 
cleft; the subsequent polymerisation into F-actin results in the hydrolysis of this ATP to 
ADP followed by release of Pj (Carlier, Pantaloni, & Korn 1987). Originally this ATPase 
activity was thought to be necessary for actin polymerisation, although this has now been 
disproved by experiments using G-actin bound to ADP or non-hydrolysable analogues of 
ATP (Pollard & Weeds 1984). Once disassociated from a filament, ADP bound to actin is 
rapidly exchanged for ATP in solution (Neidl & Engel 1979) thus allowing the cycle to 
begin again.
1.2.3 The polarity of actin polymerisatioii/depolymerisation
The concentration above which actin polymerisation, and below which depolymerisation 
occurs, is known as the critical concentration (CC) and is found to be 12 to 15 fold higher 
at the pointed than at the barbed end (Wanger & Wegner 1983). When the G-actin 
concentration is lower than the CC of the barbed end, there is no polymerisation of the 
filament; when it is higher than the CC of the pointed end, polymerisation occurs at both 
ends. When the concentration falls between the CC of both ends polymerisation only 
occurs at the barbed end. Once a steady state is reached where the rate of polymerisation 
is equal to that of depolymerisation, a treadmilling effect is observed with actin subunits 
being sequentially added to the barbed end, moving along the length of the filament, and 
dissociating from the pointed end (Fig. 1.3) (Pantaloni, Clainche, & Carlier 2001).
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Figure 1.3 The polymerisation of actin monomers into actin filaments.
(a) During the initial nucléation phase, ATP-G-actin monomers (blue) slowly 
form stable trimeric complexes which are then more rapidly elongated in the 
second phase o f polymerisation. After their incorporation into a filament, 
subunits slowly hydrolyse ATP to ADP and unreleased-phosphate(Pi) 
(purple).The ‘oldest’ or pointed end contains ADP-bound monomers from which 
the Pi has been released (pink). The actin filament displays polarity as G-actin 
adds primarily to the barbed end and loss occurs mainly at the pointed end. (b) 
There are three phases for de novo G-actin polymerisation in vitro; nucléation, 
elongation and steady state.
1.3 Saccharomyces cerevisiae as a model eukaryotic system
The structures of many proteins as well as their intra-cellular localisation and ftmctions 
are highly conserved throughout all eukaryotic organisms. Consequently, studies using 
the budding yeast S. cerevisiae as a model system have provided valuable information 
towards the understanding of a wide range of biological events within these cells and 
those of higher eukaryotes (Ayscough & Dmbin 1996).
S. cerevisiae is a unicellular organism that that exists in either haploid or diploid states, 
and grows both in liquid broth and on a solid agar plate. It can be studied using 
biochemical or immunofluorescence techniques as well as by conventional genetics with 
new strains being easily generated by crossing parental strains with different genotypes. 
The sequencing of the 6000 genes of its genome has resulted in many new proteins being 
discovered, as well as allowing previously known proteins to be easily mutated using 
PCR and other molecular biology techniques
1.3.1 F-Actin structures in S. cerevisiae
The different actin structures can be visualised in yeast by fluorescence microscopy using 
either fluorescently labelled anti-actin antibodies or rhodamine-phalloidin, a fluorescently 
labelled phallotoxin that binds to F-actin (Adams & Pringle 1991). Using these 
techniques it is possible to discern two distinct actin structures, cytoplasmic actin cables 
and cortical actin patches (Kilmartin & Adams 1984). Both structure are dynamic with 
reorganisation occurring throughout the cell cycle (Fig. 1.4) (Pruyne & Bretscher 2000). 
Their location and orientation confer polarity on a cell (Drubin & Nelson 1996) and their 
interactions with a large number of associated ABPs is thought to control the organisation 
of the actin cytoskeleton (Ayscough & Drubin 1998;Schott, Huffaker, & Bretscher 
2002;Warren et al. 2002)
1.3.2 Actin Patches
Cortical actin patches contain most of the actin in yeast and are highly motile structures 
(Doyle & Botstein 1996) containing more than 30 associated proteins
Mating
Figure 1. 4 Organisation of the actin cytoskeleton during vegetative 
growth and shmoo formation in budding yeast. Actin cables (blue) and
cortical actin patches (red) show a distinctive polarised distribution 
throughout the cell cycle and during shmoo formation for mating. Cortical 
actin patches cluster at sites o f active growth while the actin cables become 
arrayed parallel to the mother-bud axis to guide secretory vesicles and 
organelles to the sites of active growth. Adapted from Pruyne and Bretscher 
2000
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(Pruyne & Bretscher 2000). These include:- Ai'p2/3 complex (actin nucleating complex 
of 7 protein subunits), Lasl7/Beelp (nucléation regulators), Sac6p (bundling protein), 
Capl/2p (capping proteins), Panlp (Bps 15 homology), Slalp and Abplp. The patches are 
located at tubular plasma membrane invaginations (Mulholland et al. 1994) and are 
concentrated at sites of polarised growth in the yeast cell cycle (Adams & Pringle 1984). 
It is important to note that the motility of actin patches does not require the myosin motor 
proteins, but is instead reliant on the Arp2/3 complex indicating a role for actin 
polymerisation in motility (Cope et al. 1999).
The function of actin patches in the cell is still unclear, although they do appear to play 
an important role in secretion and in the internalisation step of endocytosis (Geli & 
Riezman 1998;Pruyne & Bretscher 2000). A model of this interaction (Warren, Andrews, 
Gourlay, & Ayscough 2002) utilises the Abplp binding partner Slalp as a scaffold 
protein which can link the actin patch components with the endocytic machinery through 
an interaction between the C-terminal repeats of Slalp and the EH domain-containing 
protein End3p (Fig. 1.5).
Actin patches could also play a part in cell wall synthesis, as they are concentrated at the 
sites of cell wall deposition (Adams & Pringle 1984;Kilmartin & Adams 1984) and may 
also co-Iocalise with cell wall producing enzyme 1,3-p-glucan synthase (Utsugi et al. 
2002).
1.3.3 Actin Cables
The second of the actin structures in yeast are actin cables. These align themselves along 
the mother-bud axis during polarised growth and are involved in the intracellular 
transport of organelles and vesicles (Adams & Pringle 1984;Drubin, Jones, & Wertman 
1993;Schott, Huffaker, & Bretscher 2002), as well as being implicated in the transport of 
mRNA (Kwon & Schapp 2001). Like actin patches, actin cables also contain a variety of 
ABPs including:- Sac6p (Fimbrin), Tpml/2p (Tropomyosin), B nilp (Formin), and 
Myo2/4p (classV Myosins) and are thought to assemble at the sites of exocytosis. 
Transportation along actin cables requires polymerisation, but the Arp2/3 actin nucléation 
complex is not necessary for this process (Evangelista et al. 2002).
i l
Actin Patches
EndocyticMachineryF-ACh
SHldomalr» Slalp C-ttrrrlnBCrefieBts
Figure 1.5 A model of actin patch formation
This model reveals how actin dynamics interact with the endocytic 
machinery. Actin is tethered to the membrane at the cell cortex via Abplp 
and Arp2/3 binding to LaslTp and Arklp/Prklp. Slalp can then act as a 
scaffold by binding to both Abplp and End3p; and integral member o f the 
endocytic machinery. Taken from Warren et al 2002
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A model for the formation of these actin cables (Schott, Huffaker, & Bretscher 2002) 
utilises the Rho-GTPase effector Bnilp which binds at the membrane to formin-binding 
proteins and also to profil in which recruits actin to the complex allowing the nucléation 
of an actin filaments to occur (Fig. 1.6). These actin filaments are stabilised by Tpml/2p 
and bundled into cables by Sac6p.
1.4 The dynamics of the actin cytoskeletoii are controlled by different ABPs
The diverse roles that actin plays in a cell are mediated by the large number of proteins 
which can bind to either G-actin or F-actin at a variety of binding domains therefore 
allowing multiple actin binding proteins (ABPs) to bind simultaneously. These ABPs can 
induce a reorganisation of the cytoskeleton in response to both intra- and extra-cellular 
signals and can have a variety of different fonctions (Ayscough 1998;dos Remedies, 
Chhabra, Kekic, Dedova, Tsubakihara, Berry, & Nosworthy 2003;McGough 
1998;Pollard & Borisy 2003) (fig. 1.7). These include;- sequestering G-actin, inducing 
nucléation of filaments, promoting de-polymerisation, capping filaments, severing F- 
actin, cross-linking or bundling F-actin filaments, and motor proteins like myosins that 
can transport cargo along microfilaments. Other ABPs act as scaffolds tethering actin at 
its site of activity; an example of this is the involvement of Slalp linking the actin 
cyto skeleton to the endocytic machinery (Warren, Andrews, Gourlay, & Ayscough 
2002).
1.4.1 G-actin binding proteins
One of the most studied of the G-actin binding and sequestering proteins is profilin, a 19 
kDa protein (Ampe et al 1988) that is highly expressed in the cytoplasm of eukaryotic 
cells. It was originally thought to (i) bind and sequester monomeric actin resulting in 
inhibition of actin filament growth in vitro (Carlsson et al. 1977), and (ii) inhibit the 
hydrolysis of ATP when bound to actin thereby maintaining a pool of actin primed for 
polymerisation. However it is now known that profilin promotes the exchange of 
nucleotides in actin monomers from ADP-actin to ATP-actin (Goldschmidt-Clermont et 
a l 1991) and along with cofilin plays a part in the control of actin filament
13
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Figure 1. 6 A model of actin cable formation
This model shows a complex arrangement o f actin binding proteins. The 
Rho-GTP binds to formin binding proteins which in turn bind to formin, 
resulting in a conformational change in formin which allows profilin to bind 
and recruit actin monomers to the growing actin filament These filaments are 
then stabilised by tropomyosin and bundled by fimbrin. Taken from Schott et 
al 2002.
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Figure 1.7 The function of actin-binding proteins (ABPs)
ABPs regulates actin filament structure in a variety o f different ways Specific 
functions o f actin-binding proteins as determined by in vitro research are 
shown with a diagram o f how each protein may interact with F-actin. Adapted 
from Ayscough 1998.
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treadmilling. Another role for profilin can be seen in the targeting of ATP-actin to sites of 
filament growth via its ability to bind the formin family of ABPs (Fig. 1.6) (Schott, 
Huffaker, & Bretscher 2002). It is also worth noting that dissociation of profilin from 
actin is stimulated by PIP and PIP2 (Goldschmidt-Clermont et al. 1990), indicating a 
possible role in the signalling between the cell membrane and the actin cyto skeleton.
1.4.2 Actin depolymerising proteins
Another family o f ABPs involved in the control of actin filament treadmilling is the 
ADF/cofilin family; these 15-19 kDa proteins are expressed throughout eukaryotic cells 
and exist as multiple isoforms (dos Remedios et al. 2003). Its role in treadmilling is 
achieved by increasing by about 30 fold the off rate of actin monomers from the pointed 
end of actin filaments without affecting the off rate at the barbed end (Carlier et al. 1997). 
The ADF/cofilin complex has also been implicated in the severing of actin filaments 
(Maciver et al. 1998); this could aid depolymerisation by creating more ends which could 
disassemble, although this mechanism may require the cooperative binding of two 
cofilins (Galkin et al. 2001).
The cellular functions of ADF/cofilin appear to be essential for survival since a deletion 
of the S. cerevisiae homologue COFl proves lethal (Moon & Drubin 1995). ADF/cofilin 
can be negatively regulated by phosphorylation (Moon & Diiibin 1995), and although 
this is not the case for yeast cofilin, a mutation (Ser^- Glu) that mimics the inactive state 
results in lethality (Lappalainen et al. 1997). Other factors important in the regulation of 
ADF/cofilin are membrane lipids such as PIP and PIP2, which can be inhibitory, and 
changes in pH, which can promote depolymerisation in alkaline conditions (Yonezawa & 
Nishida 1990),
1.4.3 Capping proteins
The control of the length and distribution of filaments relies on the ability of certain 
ABPs to block the addition and subtraction of actin monomers at either the barbed or the 
pointed end of the filament. Capping proteins (CAPs) are heterodimeric proteins found 
in all eukaryotic cells which act to regulate filamentous growth by binding to the barbed
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end of filaments and blocking the addition and subtraction of monomeric actin (Schafer, 
Hug, & Cooper 1995). Capping of the barbed or fast growing end results in a net increase 
in actin monomers at the pointed end, creating a pool of free G-actin available for the 
rapid polymerisation necessary for dynamic growth and motility (Hug et al. 1995). 
Another role for CAP is thought to be in nucleating new filaments; this is achieved by the 
ability o f actin monomers to add to the pointed or slow growing end under the correct 
conditions (Section 1.2.3). It is also worth noting that CAP can inhibit loss of monomers 
from the barbed end under depolymerising conditions thereby preventing filament 
shrinkage. Inhibition o f CAP by the phosphoinositides PIP and PIP2 results in its 
dissociation from the filament creating a pool of free barbed ends available for rapid 
polymerisation.
In S. cerevisiae the hetrodimeric capping protein is expressed from 2 genes CAPl and 
CAP2 (Amatruda & Cooper 1992). Deletion of these genes is not lethal although they do 
show synthetic lethality with S AC6 (fimbrin) deletions (Adams, Cooper, & Drubin 
1993). An explanation for this is that capping protein and fimbrin act together to control 
filament stability (Karpova, Tatchell, & Cooper 1995).
1.4.4 F-actin severing proteins
Gelsolin is a protein of molecular weight about 80 kDa, which belongs to a class of ABPs 
that can bind to F-actin and sever filaments in response to elevated Ca^^ levels (Yin, 
Albrecht, & Fattoum 1981). There are many different members of the gelsolin family; a 
marker for these proteins is a 120 amino acid repeat sequence of which gelsolin possesses 
six. Gelsolin has a high affinity for filaments and can cap the barbed ends after severing. 
It induces a rapid rearrangement of the cytoskeleton by creating a large number of short 
filaments, which can facilitate polymerisation by increasing the amount of free barbed 
ends (Cooper & Schafer 2000). Regulation of gelsolin is achieved through P1P2, which 
induces its dissociation from actin, and intracellular Ca^ "^  levels which not only induce 
severing but also increase the affinity of gelsolin for PIP2. Over expression studies with 
gelsolin have also suggested a role in modulating phospholipase C signalling via its 
ability to compete for PIP2 (Sun, Lin, & Yin 1997).
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1.4.5 The Arp 2/3 Complex
The Arp2/3 complex consists of two proteins structurally similar to actin, Arp2p 
andArp3p as well as five smaller unrelated (Arc) proteins (Machesky & Gould 1999). It 
appears to be conserved in all eukaryotes and is associated with regions of dynamic actin 
assembly such as membrane ruffle (Mullins, Heuser, & Pollard 1998). The main function 
of the complex is to create branch points by binding to existing filaments and nucleating 
the assembly of new filaments. This process is called dendritic nucléation and can be 
stimulated by extra-cellular signals that transmit via G-protein coupled receptors to the 
WASP (Wiscott-Aldrich syndrome protein) family of proteins (Machesky et al. 1999), 
Activated WASP binds to the complex of F- actin and Arp2/3 and induces a 
conformational change, which allows the nucléation of a new filament orthe formation of 
a Y-branch at 70° to the pre-existing one. Due to its structural similarity the Arp2/3 
complex can also mimic an actin dimer, which when bound to monomeric actin forms a 
stable nucleus (Kelleher, Atkinson, & Pollard 1995). This allows for the rapid 
polymerisation of filaments by by-passing the rate limiting actin dimérisation step 
(Section 1.2.2).h associate with the Arp2/3 com
In S. cerevisiae the WASP family proteins Lasl7p/Beelp, which associate with the 
Arp2/3 complex are found localised to cortical actin patches. Mutations in these proteins 
have shown that they are essential for patch formation and motility (Winter et al. 1997), 
as well as indicating a role for them in both endocytosis (Moreau et al. 1997) (Fig. 1.5) 
and mitochodrial motility (Boldogh et al. 2001).
1.4.6 F-actin Cross-linking or bundling proteins
The actin cytoskeleton can be stabilised by the binding of ABPs and the subsequent 
cross-linking or bundling of filaments into three-dimensional networks or tight parallel 
bundles (Ayscough 1998;Otto 1994). In order to achieve this bundling activity an ABP 
must either contain 2 actin-binding domains (ABD) or exist as a dimer containing 2 
ABDs. Fimbrin and a-actinin, both members of the calponin homology (CH) domain 
superfamily o f proteins, have been shown to induce the formation o f these higher order 
actin structures (Otto 1994). The S. cerevisiae fimbrin homologue (Sac6p) localises to
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both actin patches and cables and has been reported to be involved in regulating actin 
dynamics, endocytosis, and cell polarity in vivo (Adams, Botstein, & Dmbin 1991).
1.5 Calponin
Calponin (CaP) is a 34 kDa protein first found in smooth muscle (Takahashi, Hiwada, & 
Kokubu 1988), and was implicated in the regulation of muscle contractility via its ability 
to inhibit the actomyosin ATPase activity (Winder & Walsh 1990). To date, three 
isoforms of this protein have been isolated;- hi CaP (Takahashi, Hiwada, & Kokubu 
1988) found in the contractile apparatus of smooth muscle cells, h2 CaP (Strasser et al. 
1993) found in non-muscle cells and thought to be involved in cyto skeletal organisation 
(Danninger & Gimona 2000), and acidic CaP (Applegate et al 1994) which is found 
enriched in brain tissues and has been implicated in the regulation of neurite outgrowth 
(Ferhat et al 2001). Biochemical studies have also shown that smooth muscle CaP 
accelerates actin polymerisation at low ionic strengths and stabilises actin filaments in 
vitro (Kake et al 1995).
Although the major binding partner of CaP is actin, it also binds to large number of other 
cytoskeletal proteins including myosin (Szymanski & Tao 1993), tropomyosin (Childs et 
al 1992), desmin (Fujii et al 200), and a-actinin (Leinweber et al 1999) indicating a 
structural role within the cell. Calponin can also interact with a variety of second 
messengers including phospholipids (Fujii et al 1995), Rho-kinase (Kaneko et al 2000), 
and protein kinase C (Leinweber et al 2000) and has been suggested to play a key role in 
the linking of signalling pathways to the cytoskeleton
Calponin consists of several recognisable structural domains (Fig. 1.8) including an 
amino terminal binding site for Ca^^-binding proteins, a calponin homology (CH) 
domain, three calponin-like repeats (CLR), and a carboxy terminal tail sequence. It also 
contains two putative actin binding domains (ABDs), one (ABDl) being the region 
between the CH domain and first CLR and the other (ABD2) spanning the three CLRs, 
and including the phoshorylation site serine 175 which is thought to be involved in the 
regulation of actin binding (Winder et al 1993). The three genetic isoforms of calponin 
are highly homologous with the only major difference being
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Figure 1. 8 The domain organisation of calponin.
A protein o f 297aa with an amino terminal Ca^Vcalmodulin binding she; a 95 
aa calponin homology (CH) domain; 3 CLIK^^ Calponin Like Repeats; and a 
carboxy terminal tail sequence. Calponin also has two putative actin binding 
sites (ABS); ABSlis located in the region between the CH domain and the first 
CLR; and ABS2 spans the 3 CLRs incorporating Seri^^ which has been shown 
to be critical for actin binding. Adapted from Small and Gimona 1998.
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seen in the carboxy tail sequence where differences in both the size and charge of the 
amino acids can be observed. This region is thought to bind to residues in ABD2 and is 
predicted to have an autoinhibitory effect on actin binding (Danninger & Gimona 2000, 
Burgstaller et al 2001).
1.5.1 Calponin homology (CH) domains
The CH domain is a protein module of about 100 amino acids which is found in a variety 
of both cytoskeletal and signalling proteins and was proposed to function as an 
autonomous actin binding motif (Castresana & Saraste 1995). This hypothesis was based 
on identification of a 250 amino acid ABD found in cross-linking proteins consisting of 
two tandem repeats of about 125 amino acids corresponding to two distinct CH domains.
The ability o f the amino-terminal CH domain of a-actinin to bind actin (Way, Pope, &
Weeds 1992) and the use of EM reconstructions to show that the majority of contacts 
within the ABD of fimbrin are located on the amino-terminal CH domain supported this 
hypothesis (Hanein, Matsudaira, & DeRosier 1997). Further analysis of these domains 
resulted in a sub-division into amino-terminal CHI and carboxy-terminal CH2 domains 
with CHI or CH2 domains from different proteins showing greater homology than CHI 
and CH2 domains from the same protein. !
One problem with this classification of CH domains as prototype actin binding modules 
is that CH2 domains bind actin either weakly or not at all (Way, Pope, & Weeds 
1992; Winder et al. 1995) indicating a redundancy of this CH domain in actin binding.
The fact that CHI of a-actinin binds to actin with a lower affinity than the complete 
ABD (Way et al. 1992) suggests a stabilising role for the CH2 domain through inter­
domain helix-helix interactions and indicates a need for both CHI and CH2 domains to 
form a fully functional ABD (Goldsmith et al. 1997b). Further detailed analysis of the 
CH domain sequence have also shown that it does not overlap the ABD of CaP and that 
the CH domain in CaP and in its smooth muscle homologue SM22 are not sufficient or 
necessary for F-actin binding (Gimona & Winder 1998).
A more recent study of CH domains containing proteins (Stradal et al. 1998) classifies 
them into 3 different groups:- (i) monomeric cross-linking proteins containing two 
ABD s (fimbrin), (ii) dimeric cross-linking proteins (a-actinin , a-spectrin) and
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monomeric actin binding proteins (utrophin, dystrophin) each containing one ABD, and 
(iii) the largest and most diverse group which contain proteins with only one amino 
terminal CH domain (CaP, sm22, Vav, IQGAP). The CH domain sequences in these 
groups of proteins were analysed and classified into a further 5 sub-divisions (Fig. 1.9) 
with separate branches for CHI and CH2 domains from 1 ABD containing proteins. 
Likewise CHI domains from the ABDl and ABD2 (C H l.l and CHI.2) of fimbrin are 
more similar than corresponding CH2 domains (CH2.1 and CH2.2), and both are 
separated from other CHI and CH2 domains. Single CH domains (CH3) are also 
branched separately as they are significantly different from the CH domains that 
comprise ABDs.
The CH domain structure has been solved from several different proteins including:- 
spectrin, calponin, fimbrin, and utrophin (Bramham et al. 2002;Carugo, Banuelos, & 
Saraste 1997;Goldsmith, et al. 1997b;Keep, Norwood, Moores, Winder, & Kendrick- 
Jones 1999), and reconstructions show a high level of conservation in secondary 
structure. The CH domain of CaP (Bramham et al. 2002) is made up of four main 
a-helices (1, 3, 4 and 6) (Fig. 1.10) each comprising between 11 &18 residues joined by 
long loops, and two shorter and less regular helices (2 and 5). Helices 3, 4 and 6 form an 
inner core with the two shorter helices 2 and 5 located together at the N-termini of helices 
3 and 6 respectively. Helix 1 is hydrophobically tethered by, and lies perpendicular to, 
helices 3 and 6, as is helix 5. A 3 lo-helical turn can also be found in the long loop 
between helices 4 and 5.
1.5.2 Calponin Like Repeat (CLR)
The calponin like repeats (CLR) or CLIK^^ repeat modules (Lener, Burgstaller, & 
Gimona 2004) are 23-29 amino acid stretches which have been found on a variety of 
actin-binding proteins including;- calponin which contains three tandem repeats, the 
SM22/trangelin family o f smooth muscle proteins each of which possess one CLR, and 
the muscle protein of C. elegans UNC-87 which contains seven CLRs (Fu et al. 
2000;Gimona & Mitai 1998;Kranewitter, Ylanne, & Gimona 2001). These CLRs are
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Figure 1. 9 Phylogenetic tree of CH domains.
The analysis includes 104 individual sequences from 60 single and multiple 
CH domain-containing proteins. CH domains are sub-divided into 5 
populations;- Proteins with 2 CH domains (CHI and CH2) and one ABD; 
CHI domains from these proteins share more homology with CHI domains 
from other proteins than CH2 domains from the same protein; and vica versa. 
The CH2.1 and CH2.2 domains of fimbrin are also more similar to each other 
than to the C H l.l and CHI.2 domains. A separate branch of the tree is 
occupied with the largest group o f proteins; those that posses only 1 CH 
domain which shares a high degree o f homology with other members o f  the 
same sub-division. Taken from Gimona et al 2001.
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Fig.1.10 Ribbon diagram of CH domain structure
The CH domain o f CaP is made up of four main a-helices (1, 3, 4 and 6) 
each comprising between 11 &18 residues joined by long loops, and two 
shorter and less regular helices (2 and 5). Helices 3, 4 and 6 form an inner 
core with the two shorter helices 2 and 5 located together at the N-termini of  
helices 3 and 6 respectively. Helix 1 is hydrophobically tethered by, and lies 
perpendicular to, helices 3 and 6, as is helix 5. A 3,Q-helical turn can also be 
found in the long loop between helices 4 and 5. Taken from Bramham et al 
2002.
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highly conserved at the amino acid level and have been proposed to contain a unique 
actin-binding interface. In calponin the second ABD spans the three tandem CLRs on the 
carboxy terminal side of the CH domain (Danninger & Gimona 2000); in SM22 the 
single CLR which again lies on the carboxy terminal side of a CH domain has been 
shown to be necessary for actin binding (Fu et al. 2000); and in the case of UNC-87 
which does not contain a CH domain the multiple CLRs have been shown to bind actin 
directly and form tight F-actin bundles (Kranewitter, Ylanne, & Gimona 2001). The CLR % 
module has been identified as the domain responsible for stabilisation of actin filaments 
by calponin (Burgstaller, Kranewitter, & Gimona 2002); and it has also been shown that
■the ABD conferred by this module does not compete with other ABD’s containing 
tandem CH domains such as a-actinin (gimona et al 2002).
In the case of calponin, it has also been shown that acidic carboxy terminal tail sequences 
could play a role in the autoregulation of basic actin-binding to CLRs, which function via 
an electrostatic interaction to block the ABD2 (Danninger & Gimona 2000). CLRs also 
contain a conserved serine/threonine residue (CaP Ser^^ ,^ SM22 Ser^^^); which when 
phosphorylated interferes with CLRs binding to actin (Fu et al. 2000;Winder et al. 1993).
1.6 The smooth muscle protein SM22/transgelin
The smooth muscle protein SM22 was first isolated from chicken gizzard (Lees-Miller et 
al. 1987) as a protein with a molecular mass of 22 kDa and of unknown flinction. This 
was later shown to be the same protein as transgelin (Tgln) a shape-change-sensitive 
actin-gelling protein found in fibroblasts (Shapland et al 1988). SM22/transgelin has 
since been identified as WS3-10 in senescent human fibroblasts (Thweatt, Lumpkin, Jr., 
& Goldstein 1992), and as p27 in mouse (Almendral et al. 1989); and homologues mp20 
in D. melanogaster (Ayme-Southgate et al. 1989); and UNC-87 in C. elegans (Goetinck 
& Waterston 1994). It is detectable in some primary smooth muscle cultures but is 
rapidly lost with further time in culture (Solway et al. 1995). SM22/transgelin possesses 
two distinct domains with significant homology to calponin;- (i) an amino terminal CH 
domain and, (ii) a carboxy-terminal CLR (figure 1.11). Although SM22/transgelin 
exhibits significant homology with calponin at the amino acid sequence level, as well as
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Figure 1.11 A schematic representation of CH domain containing 
proteins: The different sub-divisions of the calponin family o f proteins 
and the domains which they share. There is fimbrin which has 4 CH 
domains and possesses 2 ABDs. Proteins like dystrophin which posses 
only 1 ABD and have 2 CH domains. The largest and most varied sub­
division o f CH domain proteins is those which which possess a single 
CH domain, these can be further sub-divided with respect to the other 
domains like CLRs and various signalling motifs that the protein may 
possess. Taken from Stradal et al 1998.
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possessing a similar domain structure, there was some controversy as to whether it could 
bind actin (Fu et al. 2000) or not (Gimona & Mital 1998).
One possible explanation for this apparent discrepancy between the results could be 
differences in experimental conditions employed during co-sedimentation assays, with Fu 
et al. 2000; reporting actin binding at low ionic strength. It has been suggested that there 
is an actin-binding site on SM22/transgelin, situated between the N-terminal CH and the 
C-terminal CLR and encompassing residues 154-161 (Prinjha et al. 1994). This putative 
ABD (154-KKAQEHKR-161) contains four positively charged residues thought to be 
important in the binding of actin through electrostatic interactions (Fu et al. 2000).
Another possible actin-binding site has been proposed to lie within the CLR and includes 
the phoshorylation site at Ser^^\ which in vitro has been shown to be phosphorylated by 
PKC, resulting in an inhibition of actin-binding (Fu et al. 2000). SM22/transgelin also 
possesses a putative EF hand motif at residues 108-119, which appears to be non­
functional as Ca^^ has no effect on actin-binding (Lawson, Harrison, & Shapland 1997). 
SM22/transgelin serves as an early marker o f smooth muscle tissue as it appears late in 
the embryonic development of chicken relative to other components of smooth muscle 
cytoskeleton . Whereas Sm22/transgelin has been shown to bind actin, the function of :this protein in higher eukaryotes has remained uncertain, with mice deficient for the 
smooth muscle variant SM22a exhibiting no overt smooth muscle phenotype (Zhang et ial. 2001). It is also interesting to note that the expression pattern of this protein in various 
primary and cultured cells shows it to be a transformation- and age-sensitive protein 
(Gonos et al. 1998).
1.9 Discovery of a calponin homologue (Scplp) in Saccharomyces cerevisiae
A search of the yeast genome identified a single open reading frame with homology to 
the calponin family o f proteins (Epp & Chant 1997). Sequence analysis o f this gene 
identified a single amino terminal calponin homology (CH) domain, and a single 27 
amino acid calponin-like repeat (CLR) (Fig. 1.11) as had been identified previously in 
SM22/transgelin, a subfamily of CH domain proteins. Indeed Scplp shares 28% identity 
and 48% similarity with SM22/transgelin at the amino acid sequence level. The protein 
Scplp has a molecular mass of 22 kDa and is basic in nature with a predicted pi of 9,5.
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1.10 Aims of the present work
The functions of the SM22/transgelin family o f proteins within the cell have yet to be 
fully understood, with conflicting reports surrounding their role in actin-binding/bundling 
(Fu et al. 2000;Gimona & Mital 1998) and SM22 knockout mice showing no discernible 
smooth muscle phenotype (Zhang et al. 2001). In this work, the aims were to:- (i) purify 
Scplp, a member of the SM22/transgelin family; (ii) use a range biochemical techniques 
to identify and characterise actin-binding properties of Scplp; and (iii) identify a role for 
Scplp in vivo.
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2. Materials and Methods
2.1 Molecular Biology Techniques
2.1.1 Restriction enzyme digestion of DNA
All enzymes used in this study were from New England Biolabs and digests were carried 
out according to the manufacturer’s instructions, using the buffers supplied. Digests were 
typically performed in a final volume of 20 pi, using 2-10 units of enzyme per reaction. 
Double digests were performed where necessary when buffer conditions were compatible 
keeping the volume of enzyme added per reaction under 10% of the reaction volume. 
Nuclease-free water was added as required to make up the appropriate final volume. Most 
digests were carried out at 37°C for 2-3 hours unless otherwise recommended by the 
manufacturer.
2.1.2 Plasmid DNApurification using the Qiagen preparation system
Purification of plasmid DNA was prepared using the Qiagen DNA purification system 
(mini, midi, maxi or giga) according to the manufacturer’s instructions. This system was 
based on the alkaline lysis method of DNA purification followed by purification of the 
DNA on a silica-based resin. The DNA was eluted from the resin in 50 pi of 1 X TE (10 
luM Tris-HCl, 1 mM EDTA, pH 7.5) or sterile distilled water. All plasmid DNA was 
purified in this way if it was needed for DNA sequencing or for use in transformations.
2.1.3 Electrophoresis of DNA using agarose gels.
DNA fragments were routinely separated and visualised using flat bed agarose gel 
electrophoresis. Agarose gels were made by melting 0.8 % agarose in TAB (10 mM 
Tris/HCl, 1 mM EDTA, pH 7.5). 5 pi of a 10 mg mf^stock of ethidium bromide was 
added per 50 ml o f agarose solution. The solution was then poured into a casting tray
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containing a comb with the required number of teeth. After the gel had set, the DNA was 
mixed with 6x gel loading solution (0.25 % Bromophenol Blue, 0.25 % Xylene Cyanol 
FF, 30 % glycerol in water) and then loaded into the wells of the gel. Samples were 
subjected to electrophoresis in 1 x TAB at between 80 and 120 V until the bromophenol 
blue of the loading solution had run between 2.5 and 5 cm. The DNA was then visualised 
by illuminating the gel with an UV light source.
2.1.4 DNA ligation
DNA ligation was performed using a Rapid DNA ligation kit (Roche Diagnostics). 
Vector and insert DNA were diluted in DNA dilution buffer to a final volume of 10 pi. 
10 pi of 2 X DNA ligase buffer was then added along with 1 pi of T4 DNA ligase. A 
control reaction containing cut vector and no insert DNA was also set up. The contents 
were mixed well and incubated at room temperature for 5 min. 2 pi of the ligation mix 
was used to transform ultra-competent XL2 blue E. coli cells (Stratagene).
2.1.5 Amplification of DNA using the polymerase chain reaction
The polymerase chain reaction (PCR) is a method used to amplify specific DNA 
fragments using oligonucleotide primers complementary in sequence to the regions 
flanking the sequence of interest. PCR was used on several occasions during this project; 
the method described here was a general PCR method used to amplify sequences from 
plasmids designed to allow deletion or tagging of genes within the yeast genome. 
Routinely PCR carried out during this study was performed using Bioline reagents.
For each PCR reaction the following were mixed in 0.5 ml thin-walled PCR tubes: 1 X 
Tag reaction buffer, 200 nM dNTP’s, 1.5 mM mgCb, 1 pM forward primer, 1 pM 
reverse primer, 1 pi template DNA, 1 pi Bioline Taq (5 Upf^) and water to 100 pi. The 
components were mixed gently. A general PCR occurred over 30 cycles of amplification 
in a MWG Biotech Primus PCR machine, each involving steps of 94°C (1 min), 55°C (2 
min), 72“C (1-4 min). Cycling parameters varied according to length of final product: 1- 
minute extension time (72 °C) was allowed per 1 kb to be amplified. A final elongation 
step was used at the end of the amplification cycles by incubating at 72°C for 5 min. The
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resulting product was analysed by electrophoresis on a 0.8 % agarose gel to detect the 
amplification products.
2.1.6 Bacterial growth media
The following media were used for the growth and maintenance of various E. coli strains 
used throughout this study.
2xYT (1.6 % tryptone, 1 % yeast extract, 0.5 % NaCl in water) for liquid medium and 
2xYT with 2 % agar added for solid medium.
When preparing media for growth ofE.  coli strains harbouring a plasmid conferring 
antibiotic resistance, the medium was supplemented with the appropriate antibiotic. 
Ampicillin (100 mg mf^ stock) was added to a final concentration of 100 pg m f\
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2.1.7 Preparation of calcium-competent DH5a cells.
An overnight culture of DH5a cells was diluted into 100 ml of 2xYT liquid. Cultures 
were then incubated at 37 °C until the Aaoo reached 0.5-0.6. The culture was split into 50 
ml centrifuge tubes and placed on ice for 10 min. Cells were harvested by centrifugation 
in a Heraeus megafuge at 600 g  for 5 min at 4 °C. The cell pellet was re-suspended in 50 
ml o f ice cold 100 mM CaCL and incubated on ice for between 30 min and 4 h. Cells 
were again harvested by centrifugation and the cell pellet was resuspended in 5 ml CaCL 
+ 15 % glycerol. 50 pi aliquots were snap frozen in liquid nitrogen and stored at -80 °C.
2.1.8 Transformation of DNA into E. coli
1 pi of DNA was added to 50 pi of competent E. coli cells (either D H5a or BL-21); this 
was incubated at 4°C for 1 hr, before being heat shocked at 42°C for 2 min. Cells were 
allowed to recover by adding 500 pi of 2xYT media and incubating at 37“C for 1 h and 
then centrifuged at 6000 g  for 2 min, pellets were re-suspended in 100 pi of 2xYT media
'
and plated out on 2xYT plates containing appropriate antibiotics. The plates were then 
incubated at 37“C overnight.
2.1.9 Bacterial glycerol stocks lycerol stocks
For long-term storage of bacteria, 1 ml culture was mixed with 1 ml 50 % sterile glycerol 
in a cryovial and then stored in a -80 °C freezer
2.2 Protein Purification Techniques
2.2.1 Expression of protein from E. coli
E. coli cells transformed with an expression plasmid containing the protein of interest 
were grown at 37°C to an Aeoo of 0.8, and then induced by the addition of IPTGto a final 
concentration of 0.5 mM for between 4 and 16 h depending on levels o f expression 
achieved. 1 ml samples were taken before and after induction to check for expression of 
desired protein.
2.2.2 Purification of expressed proteins from E. coli inclusion bodies
1 litre cultures of E. coli induced to express appropriate proteins were centrifuged at 
4000g for 20 min, the supernatant was discarded and the pellet was frozen at -2 0 “C. This 
pellet was then suspended in 50 ml of SET solution (25% Sucrose, 20 mM Tris/HCl pH 
8.0, 1 mM EDTA) containing 5 mg lysosyme and a protease inhibitor cocktail, and 
stirred at room temperature for 30 min. 50 pi of MnCl2 (l M), 0.5ml MgCE (1 M), and 5 
pi of DNAse was added to the suspension, which was then stirred for a further 10 min at 
room temperature. The suspension was centrifuged at 20000 g  for 20 min and the 
supernatant discarded. The pellet was resuspended in 50 ml TDEN solution (20 mM 
Tris/HCl pH 8.0, 2 mM EGTA, 0.2 M NaCl, 1 % deoxycholic acid) and centrifuged at 
8000 g  for 5 min. The pellet was resuspended in 50 ml TDE solution (20 mM Tris/HCl
pH 8.0, 1 mMEGTA, 0.25 % deoxycholic acid) and centrifuged at 8000 g  for 5 min. The 
washing with TDE solution and centrifugation step was repeated 5-7 times, or until the 
pellet was no longer white but grey. At this point the pellet was dissolved in 20 ml 8 M 
urea, 20 mM Tris/HCl pH 8.0, 1 mM EGTA, and then diluted to a final concentration of 
6 M  with 20 mM Tris/HCl pH 8.0, 1 mM EGTA. This solution was centrifuged at 50000 
g  for 1 h at 4°C, and the supernatant consisting of soluble inclusion body proteins was 
retained.
2.2.4 Gel filtration chromatography
A gel filtration column was poured using Sephacryl S-200 resin, which had been washed 
with a buffer appropriate for the particular protein being purified (6 M urea, 20 mM 
Tris/HCl pH 8.0, 1 mM EGTA for Scplp purification). The column was then equilibrated 
with 2 volumes of the same wash buffer. Samples of proteins to be purified were 
concentrated using a Micro-con concentrator to approximately 5 ml before being loaded 
onto the column; the column was then washed with the same buffer until the protein had 
been completely eluted. Fractions (5 ml) were collected from when the sample had been 
loaded and analysed by SDS-PAGE.
2.2.3 Ion exchange chromatography
An ion exchange column was prepared using CM-CL6B Sepharose resin which had been 
washed with a buffer appropriate for the particular protein being purified (6 M urea, 20 
mM Tris/HCl pH 8.0, 1 mM EGTA for Scplp purification). The column was equilibrated 
with the 3 volumes of the same wash buffer, and then the protein sample was pumped f
onto the column at a rate of 50 ml/min. The column was then washed with this buffer 
until a peak representing the unbound protein eluted. At this point a 1-500 mM NaCl 
gradient dissolved in the same buffer was applied to the column and the eluted protein 
collected in 5 ml fractions and analysed using SDS-PAGE.
2.2.5 Hydroxyapatite column purification
Hydroxyapatite resin was washed in a buffer appropriate for the protein being purified (6 
M urea, 20 mM Tris/HCl pH 8.0, 1 mM EGTA for Scplp purification). It was allowed to 
settle, and the fine particles poured off, before the resin was poured into a column. This 
was then equilibrated with 2 volumes o f the same wash buffer. Before loading samples 
were concentrated down using a Micro-con concentrator to approximately 5 ml; after this 
the column was washed in 1 volume o f buffer before the protein was eluted using a 1- 
lOOmM K2HPO4  gradient dissolved in the same buffer. The column flow rate was kept at 
or below 20 ml/h to prevent compression of the resin. Fractions (5 ml) were collected and 
then analysed then analysed by SDS-PAGE.
2.2.6 Production of anti-Scplp antibody
250 jul of purified Scplp (0.75 mg mf^) was mixed in equal volumes with 2 x sample 
buffer (detailed in section 2.5.1), and loaded into a well of a 12.5 % protein gel (Biorad 
protean II system). This was then run for 16 h at 9 V in 1 x lunning buffer (detailed in 
section 2.5.2) before being stained with Ponceau red to visualise the purified protein 
band. The band was cut out and finely ground up after freezing in Liquid Nitrogen. This 
material was split into 4 aliquots and sent to the Scottish Antibody Production Unit
(SAPU), Carluke, Lanarkshire for injection into rabbits.
.
2.2.7 Purification of anti-Scplp antibodies, (a) Pre-coupling to beads
Ig CNBr-Sepharose-4B was taken and swollen and washed with 200 ml 1 M HCl for 15 
min. The beads were then washed with 200 ml Scplp-buffer (10 mM Mes pH 6.0, 1 mM 
EGTA), and incubated with 7 ml purified Scplp (0.288 mg mf^) for 2 h at room 
temperature. The mixture was centrifuged at 4000 g  and the supernatant removed. The 
A280 was checked to make sure that at least some protein had bound to the beads. The 
beads were then washed twice in Scplp-buffer (7 ml), and then blocked by reaction with 
0,1 M Tris/HCl pH 8.0 for 16 h at 4°C. The blocked beads were then washed with 100
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ml 0.1 MNaOAc, 0.5 M NaCl pH 4.0 and then with 100 ml 0.1 M Tris/HCl, 0.5 M NaCl, 
pH 8.0. The last 2 washes were repeated twice more before the beads were stored at 4“C 
in 3.5 ml 0.1 M Tris/HCl, 0.5 M NaCl pH 8.0.
2.2.8 Purification of anti-Scplp antibodies, (b) Preparation of column
The pre-coupled Scplp-CNBr Sepharose (approx. 2.5 ml) was poured into a 10 ml 
column and washed with 25 ml of each of the following buffers (i) 10 mM Tris/HCl, 0.5 
M NaCl pH 7.5, (ii) 1 M glycine pH 2,5, (iii) 10 mM Tris/HCl pH 8.8, (iv) 0.1 M 
Triethylamine pH 11.3, (v) 10 mM Tris/HCl pH 7.5. The washed column was stored at 
4°C.
2.2.9 Purification of Scplp anti-antibodies, (c) Affinity purification
Serum was diluted to 10 ml with 10 mM Tris/HCl pH 7.5 and this was passed tlirough the 
affinity column 3 times and the column was then washed with 30 ml of (i) 10 mM 
Tris/HCl pH 7.5, (ii) 10 mM Tris HCl/HCl, 0.5 M NaCl pH 7.5. The bound acidic 
proteins were eluted with 10 ml of 0,1 M glycine/HCl pH 2.5; 1 ml fractions were 
collected into tubes containing 0.1 ml 0.1 M Tris/HCl pH 8.0. The column was then 
washed with 30 ml 10 mM Tris/HCl pH 8.8, before the bound basic proteins were eluted 
with 5 ml O.IM Triethylamine pH 11.3. Fractions (1 ml) were collected into tubes 
containing 0.1 ml 0. IM  Tris pH 8.0. The A280 o f each fraction was measured and those 
fractions which contain protein (antibody) were pooled, before being dialysed overnight 
against PBS (50 luM Na2HP04, 150 mM NaCl pH 7.5).
2.2.10 Purification of GST-fusion and 6x HIS tagged proteins proteins
These were grown up as 1 litre cultures and purified according to the manufacturers 
recommendations , GST-fusion proteins (pGEX -Amersham Bioscience), 6xHis-tagged 
(pET -  Novagen).
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92.3 Actin-binding experiments
2.3.1 Falling Ball Assay
Actin (5-10 |j,M) was mixed with Sep Ip ranging in concentration from 0-10 \xM, in a 
total volume of at least 90 pi (made up with Scplp-buffer) and polymerisation was 
initiated with the addition of 10 x KME mix (1 M KCl, 20 mM MgCl, and 10 mM 
EGTA). Some of this mixture was immediately drawn up into a 100 mm x 1 mm 
diameter capillary tube and allowed to polymerise for at least 2 h; the remaining reaction 
was set aside for sedimentation assay (Sections 2.3.2 and 2.3.3). After polymerisation had 
taken place a 1 mm diameter ball bearing was placed at the top of the capillary tube, and 
the time it took to travel the 100 mm down the capillary was recorded.
2.3.2 Low speed sedimentation assays
Actin (5-10 pM) was mixed with Sep Ip ranging in concentration from 0-10 pM, in a 
total volume of at least 45 pi (made up with Scplp-buffer) and polymerisation was 
initiated with the addition of 10 x KME mix. The mixture was then allowed to polymerise 
for at least 2 h, before being centrifuged at 13000 g  for 15 min. The supernatant was 
transferred to a fresh tube, and both it and the pellet fraction were made up to the same 
volume with sample buffer before being analysed by SDS-PAGE and stained with 
Coomassie Blue in order to quantitate the amount of protein in each of the fractions.
2.3.3 High speed sedimentation assays
Actin (5-10 pM) was mixed with Sep Ip ranging in concentration from 0-10 pM, in a 
total volume of at least 90 pi (made up with Scplp-buffer) and polymerisation was 
initiated with the addition of 10 x KME mix. The mixture was then allowed to polymerise 
for at least 2 h, before being centrifuged at 100000 g  for 15 min. The supernatant was 
transferred to a fresh tube, and both it and the pellet fraction were made up to the same
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2.3.4 Electron microscopy
2.3.5 Pyrene actin polymerisation/depoïymerisation assay
Actin (1 pM) was mixed with pyrene-labelied actin (supplied by Dr SJ. Winder). Scplp 
was then added at concentrations ranging from 0-5 pM and polymerisation was initiated 
with addition of 10 x KME mix. The resulting rates of polymerisation were measured 
using a Perkin Elmer LS-50B spectrofluorimeter over the course of 1000 s with the 
parameters set at: excitation wavelength = 366 nm, emission wavelength = 387 nm and 
slit widths = 4.0 nm. Measurements where also taken after 24 h to analyse steady state 
kinetics. Depolymerisation was achieved by a 1:10 dilution of the polymerised actin 
solution into a buffer lacking polymerisation mix.
2.4 Fluorescence microscopy techniques
2.4.1 Rd-phalloidin staining of actin
Yeast strains were grown up in YPAD liqud medium (detailed in section 2.6.1) to an A^ oo 
0.1-0.3 and a 1 ml sample was placed in a fresh Eppendorf tube. 0.134 ml 37 %
volume with sample buffer before being analysed by SDS-PAGE and stained with 
Coomassie Blue in order to quantitate the amount of protein in each of the fractions.
Actin was mixed with Scplp (1 pM) or Scplp buffer in a volume of 50 pi (made up with 7Scplp buffer) and polymerisation initiated by addition of 10 x KME. The mixture was :
then allowed to polymerise for at least 2 h, before being spotted onto a carbon fbrmvar- fs
coated disc and the excess fluid absorbed off using a piece of tissue. This was then 
stained with 5 pi Nanovan (Universal Biologicals); again the excess fluid was absorbed '■g
with a piece of tissue. The contents of the disc were then visualised on a Zeiss 902
7;electron microscope.
'I
formaldehyde was added and the mixture was left at room temperature for 1 h. The cells 
were centrifuged at 3000 g  for 5 min and washed twice in 1 ml PBS, 1 mg ml'^ BSA, 0.1 
% TritonX-100 with the final re-suspension in 50 pi PBS, 1 mg mf^ BSA, 0.1 % 
TritonX-100 to which 5 pi o f Rd- phalloidin (40 mg mf^) was added. This was then left 
to incubate for 30 min in the dark. After this the cells were washed twice with 1 ml PBS 
containing 1 mg ml"^  BSA and then re-suspended in 200 pi of this buffer. 20 pi of this 
suspension was left to settle on the well of a slide pre-coated with poly-L-lysine for 10 
min before being washed 3 times on the slide with PBS containing 1 mg ml'^ BSA. 
Mounting solution (1 drop) was added to the slide, a glass coverslip placed on top, and 
the sides then sealed with nail varnish. Cells were examined by fluorescence microscopy 
either immediately or after storage at -20°C until convenient.
2.4.2 Immunofluorescence
Yeast strains were grown up in YPAD liquid medium (detailed in Section 2.6.1) to an 
Aeoo 0.1-0.3 and a 5 ml sample was placed in a fresh Falcon tube. 0.67 ml 37 % 
formaldehyde was added and the mixture left at room temperature for 1 h. The cells were 
centrifuged at 3000 g  for 5 min and washed twice with 2ml sorbitol buffer (1.2M sorbitol, 
O.IM potassium phosphate buffer, pH 7.5) before being re-suspended in 0.5ml sorbitol 
buffer to which 20pl 1 mg ml'^ zymolyase and 1 pi of 2-mercaptoethanol was added. The 
suspension was left to incubate for 30-40 min at 37°C. 20 pi of this suspension was left to 
settle on the well of a slide pre-coated with poly-L-lysine for 10 min before was removed 
by aspiration. The cells were then permeabilised with 10 pi 0.1 % SDS for 30 s before 
being washed 10 times per well with PBS containing 1 mg mf^ BSA. Care was taken not 
to let the wells on the slide dry out during this procedure. The primary antibody was 
diluted as necessary in PBS containing 1 mg ml"^  BSA and 15 pi placed on each well and 
left to incubate for 1 h. Each well was then washed 10 times with PBS containing 1 mg 
ml'^BSA before 15 pi of the secondary antibody (diluted as necessary in PBS containing 
1 mg ml'^ BSA) was added. The slide was incubated for 1 h in the dark, so as to not 
bleach the fluorophore, and the wells washed a further 10 times with PBS containing 1 
mg ml'^ BSA. Mounting solution (1 drop) was added to the slide, a glass cover slip placed 
on top and the sides then sealed with nail varnish. Cells were examined by fluorescence 
microscopy either immediately or after storage at -20°C until convenient.
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2.4.3 Mounting medium containing DAPI for staining of DNA
100 mgp-phenylenediamine was dissolved in 10 ml PBS (pH 9.0). 90 ml glycerol was 
added to this solutionand the mixture and stirred until homogeneous. 2.25 pi DAPI stock 
(1 mg ml"  ^4 ,6 diamidino-2-phenylindole dihydrochloride in water) was added and 
mounting medium was stored in the dark at either -80°C (long term) or -2 0 "C (short 
term).
2.4.4 Adhering cells to microscope slides
To prevent cells from moving during photography they were fixed to the slide surface 
with poly-L-lysine as follows: 10 pi 1 mg mf^ poly-L-lysine was placed on each well of 
a slide and allowed to incubate for 1 to 2 min before being rinsed off with distilled water 
and air dried.
2.4.5 Viewing cells by fluorescence microscopy
Cells were viewed with an Olympus BX-60 fluorescence microscope with a 100 W 
mercury lamp and an Olympus lOOx Plan-NeoFluar oil-immersion objective. Images 
were captured using a Roper Scientific MicroMax 140IE cooled CCD camera using 
Scanalytics IP lab software on an Apple Macintosh 7300 computer.
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2.5 Protein methods
2.5.1 Preparation of 2 x Sample Buffer
This contains
2.5 ml 0.5 M Tris/HCl pH 6.8 2.0 ml HgO
2.0 ml 10 % (w/v) SDS 1.0 ml 2-mercaptoethanol
2.0 ml glycerol 0.5 ml 0.5 % (w/v) bromophenol blue solution
2.5.2 SDS-PAGE
5 % Stacking gel:
Sterile water 1.71 ml
30 % acrylamide, 0.8 % bisacrylamide 0.50 ml
0.5 M Tris/HCl (pH 6.8), 0.4 % (w/v) SDS 0.75 ml
10 % ammonium persulfate in H2O 35 pi
TEMED 3.5 pi
The appropriate percentage of acrylamide gel was poured according to the recipes below. 
Separating gel:
7.5 % 10% 12%
Sterile water 4.10 ml 3.44 ml 2.69 ml
30 % (w/v) acrylamide 0.8 % (w/v)bisacrylamide 2.25 ml 3.00 ml 3.75 ml
1.5 M Tris-HCl (pH 8.8), 0.4 % (w/v) SDS 2.25 ml 2.25 ml 2.25 ml Î
10 % ammonium persulfate in H2O 31 pi 31 pi 31 pi :
TEMED 5 pi 5 pi 5 pi
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Gels were run in 1 x running buffer (0.025 M Tris/HCl, 0.192 M Glycine, 0.1 % (w/v) 
SDS, pH 8.6) at 120 volts for approximately 1.5 hours, until the dye front was close to 
the bottom of the gel.
2.5.3 Coomassie blue staining of SDS-polyacrylamide gels
After electrophoresis, the gel was soaked in Coomassie stain solution (0.2 % (w/v) 
Coomassie Brilliant Blue R250, 50 % (v/v) methanol, 7 % (v/v) acetic acid, 43 % (v/v) 
H2O) for 5 min with continuous movement on a rocking platform. The gel was then de­
stained using several changes of 50 % (v/v) methanol, 7 % (v/v) acetic acid, 43 % (v/v) 
H2O until the protein bands became clearly visible.
2.5.4 Western blotting
Proteins were separated by SDS-PAGE as described (sections 2.5.2 and 2.5.3). PVDF 
(Schleicher and Schuell) was soaked in methanol while the filter paper and two pieces of 
Whatman 3MM paper cut to the same size as the gel were soaked in ice-cold blotting 
buffer (10 mM CAPS, 10 % (v/v) methanol, pH 11). The blot sandwich was assembled 
(Whatman 3MM paper, PVDF, gel, Whatman paper) keeping the assembly wet and 
taking care to exclude air bubbles. The sandwich was then placed in the blotting 
apparatus, with the membrane against the anode. An ice pack was placed in the apparatus 
to keep the blotting buffer cool and transfer was performed at 400 mA for one hour.
2.5.5 Western blot detection; Enhanced Chemi-Luminescence (ECL)
Proteins were blotted as described (section 2.5.4). The wet membrane was blocked at 
room temperature for about 1 h, or overnight at 4°C, in 5 % (w/v) milk powder in TBST 
(50mM Tris/HCl, 150 mMNaCl, 0.2 % (v/v) Tween-20 pH 7.4). The membrane was 
then rinse briefly in 1 x TBST then sealed in flat plastic tubing (cut to about the same size 
as the membrane) with 2 ml blocking solution plus the primary antibody. The membrane 
was incubated in the presence of primary antibody 1 h at room temperature. The blot was
then removed from the tubing and washed with TBST (100 ml) briefly followed by three 
10 minute washes in TBST (100 ml). The membrane was sealed in flat plastic tubing 
(cut to about the same size as the membrane) with 2 ml blocking solution containing 
secondary antibody conjugated to horseradish peroxidase for between 30 min and 1 h at 
room temperature. The membrane was removed from the plastic tubing then washed 3 
times with TBST (100ml) for 15 min each time.
Equal volumes (5 ml) of developing reagents (Solution I: 250 luM luminol (3-
aminophthalhydrazide (Fluka) in DMSO, 90 mM p-coumaric acid in DMSO, 0.1 M Tris
HCl pH 8.5; Solution II: hydrogen peroxide, 0.1 M Tris/HCl pH 8.5) were mixed in the
.dark room and the membrane was incubated in the developing solution for at least 1 min. 
The reagents were then drained off and the membrane sealed between sheets of clear 
plastic film. The membrane was exposed to X-ray film (Kodak) in a cassette and the film 
was developed in a Xomat automatic developer.
2.6 Yeast Methods
2.6.1 Yeast Growth Media
The following media were used for the growth and maintenance of S. cerevisiae strains 
used throughout this study.
Drop out media
Synthetic minimal medium is supplemented with the appropriate amino acids for 
complementation of any auxotrophic deficiencies. When selecting for a plasmid or gene 
marked with an auxotrophic marker, the relevant supplement was omitted from the 
medium (i.e. dropped out). Synthetic complete mixture (containing all amino acids except 
those required for the auxotrophic selection of plasmids) was prepared and added to the 
medium.
0.67% nitrogen base without amino acids (Difco)
Drop out mix (added as directed)
Solid media were supplemented with 2% (w/v) agar.
43
YPA
1% (w/v) yeast extract 
2% (w/v) peptone 
0.02% (w/v) adenine
Solid media were supplemented with 2% (w/v) agar.
Sporulation media 
1% (w/v) potassium acetate 
2% (w/v) agar
Carbon source
YPA and drop out media were routinely supplemented after sterilisation with glucose 
(sterilised 40% (v/v) stock solution) to 2% (v/v) final concentration and the letter D 
(dextrose) added to the end of the media it supplements.
Antibiotic supplement
Where cells were transformed with DNA conferring G418 resistance (KanMx marker), 
G418 (200 mg ml" ^  stock solution) was added to a final concentration of 200 pg ml \  
Media were cooled to 50°C prior to addition of antibiotic. Poured plates were 
immediately stored at 4“C in the dark.
2.6.2 Mating yeast cells
Cells o f opposite mating type were patched onto one another and allowed to grow at 29°C 
for 1 to 2 days on low glucose (0.1 % (v/v) YPA media. Zygotes were selected either 
manually using a Singer micromanipulator or by growth on media to select for diploids.
2.6.3 Sporulation and tetrad dissection
Diploid strains to be sporulated were grown on YPAD plates overnight at 29X . Cells 
were patched onto a sporulation plate and left on the bench for up to five days. The plate 
was monitored daily after 2 days to check the extent of development of four-spored asci.
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When these were plentiful, cells were taken from the plate using a toothpick and were 
resuspended in 100 pi filter sterilised 0.1 M potassium phosphate buffer pH 7.4 
containing 0.5 mg ml'^ lOOT zymolyase (ICN Biomedical) and incubated for 10 min at 
room temperature. Once digested, spores were struck onto YPAD plates, placed under a 
micromanipulator (Singer) with the needle beneath and facing up toward the cells on the 
plate. Looking down the eyepiece of the micromanipulator, the region of spread cells 
was located and tetrads isolated and dissected into rows of four spores on the YPAD plate 
using the x and y co-ordinates. When sufficient spores were isolated the plate was 
incubated at 29 °C until the spores germinated and became visible. The number of viable 
spores was noted and they were patched onto YPAD or selective plates to test for genetic 
markers.
2.6.4 Yeast Transformation
Cells were grown to mid log phase (Agoo -  0.5). 15 ml cell suspension was centrifuged at 
600g for 5 min and washed once in TE (10 mM Tris/HCl, 1 mM EDTA pH 7.5) and once 
in O.IM lithium acetate made up in TE. Cells were then resuspended in 100 pi 0.1 M 
Lithium acetate/ TE. In a separate tube 15 pi 10 mg ml'^ herring sperm DNA, which had 
been boiled for 15 min was mixed with 0.1 to 1 pg transforming DNA. This mixture was 
then vortexed briefly, 700 pi 40 % (v/v) PEG4000 in TE containing 0.1 M lithium acetate 
was added and the mixture vortexed again. The transformation mixture was incubated at 
room temperature for 90 min on a mechanical rotator before being heat shocked at 42°C 
for 15 min. Cells were spun down in a microfiige (3000 g  for 1 min) and resuspended in 
100 pi of sterile water and plated out on selective plates (see Section 2.6.1 for yeast 
selection media).
2.6.5 Temperature sensitivity of yeast on solid growth medium.
A single colony o f cells was picked using a toothpick and was resupended in 100 pi 
water. 3 pi of diluted yeast were added to YPAD plates and incubated at either 30°C or 
37°C for 1 to 2 days to assess whether a strain had a temperature-sensitive defect.
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2.6.6 Glycerol Stocks of yeast cells
For long-term storage of yeast, 1 ml culture was mixed with 1 ml 50 % sterile glycerol in 
a cryovial and then stored in a -80°C freezer.
2.7 Materials
All chemicals used were from Merck or Sigma unless otherwise stated.
2.8 Molecular and cell biology tools
2.8.1 Plasmid DNA
pKA280 = p416MET25 vector (Mumberg et al 1994) containing SCPl coding sequence 
excised from an E cd ^ tX h o l digestion of pSJW l-SCPl
pKA281 = p426MET25 vector (Mumberg et al 1994) containing SCPl coding sequence 
excised from oxvE co^X hol digestion of pSJWl-SCPI
pSJW l-SCPI = modified pET (Winder & Kendrick-Jones 1995) vector containing SCPl 
generated by PCR amplification of the SCPl coding sequence from genomic DNA and 
cloned into NdeVSaE restriction sites
pGEX-4T-SCPl = pGEX-4T vector (Amersmam Bioscience) containing SCPl 
generated by PCR amplification of the SCPl coding sequence from pSJWl-SCP and 
cloned into Eco^JJXhoi restriction sites
pC-termSCPl-GST = pGEX-4T vector (Amersmam Bioscience) containing SCPl 
generated by PCR amplification of the C-terminal SCPl coding sequence (142 -  200) 
from pGEX-SCP and cloned into EcdRifXhol restriction sites
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pN-terraSCPl“GST = pGEX-4T vector (Amersmam Bio science) containing SCPl 
generated by PCR amplification of the N-terminal SCPl coding sequence (1 -  142) from 
pGEX-SCP and cloned into EcoBUXhol restriction sites
pC-termSCPl-HIS = pET14b vector (Novagen) containing SCPl generated by PCR by 
PCR amplification of the C-terminal SCPl coding sequence (142 -  200) from pSJWl- 
SCP and cloned into Ahfel/ATioI restriction sites
pGFP-SCPl = This plasmid was generated by Dr K. Ays cough (Winder, Jess, & 
Ayscough 2003). An N-terminal GFP tagged SCPl was generated by PCR of SCPl from 
genomic DNA
2.8.2 Oligonucleotides
OkaaSSF:- 5’- SCPl oligos for GST fusion in pGEX4T:
GAT CG G ATCCAT GAG TTA CGA TAA GAA G 
BamHl site(underline)
Gka86R:- 5’- CTA GCT CGA GAA CTA TAT CTC TCC GTT G
Oka254F:- 5’- For amplyfing C-term. of Scpl
GAT GAA TTC CAT ACA GAT AGA TTT CCA GGT-3’
Gka255R:- 5 -CTA GCT CGA GTT ATT TTT TGT TGG CGT AAC GAG-3’
Gka338:- 5 - GCC AAC CAT ATG \CAT ACA GAT AGA TTT CCA GTT\
Slash position indicated 418 and 438 of Scpl
2.8.3 Yeast Strains
KAY446 haploid a his3Al, leu2A, ura3A, metl5A
KAY448 haploid a his3Al, leu2A, ura3A, metlSA, AScpl::KanMx
KAY449 haploid a  his3Al, leu2A, ura3A, lys2A, AScpl: KanMx
KAY337 a, Aerg6::LEU2, Apdr5;;TRPl, Asng2::hisG, ura3-52, lys2-801(oc), ade2- 
lOl(am), trpl-A63, his3A200, Ieu2-Al.
KAY348 haploid a , trpl-1 (am), his3A200, leu2-3,112, ura3-52, lys2-801(oc), 
sac6:;URA3, heat sensitive.
KAY349 haploid a, trpl-l(am ), his3A200, leu2-3,112, ura3-52, lys2-801(oc), sac6;;URA3, 
sensitive.
KAY115 haploid a, rho+, ade2-101 (am), his3-ll, 15 leu2-3,112 trpl-1 (am) ura3-l 
cap2-Al::HIS3
KAY604 KAY447 transformation with pKA256 (empty vector) MAT a  his3Al leu2A 
lys2A ura3
KAY646 KAY446 (Research Genetics BY4741) MATa his3Al leu2A metlSA ura3A, 
pKA280+Scplp (EcoRl/Xhol)
KAY647 As above but pKA281+ Scplp (EcoRl/Xhol), overexpressing Scpl.
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3. Results
3.1 Purification of Scplp
3.1.1 Expression of Scplp
The vector pSJW l- SCPl was transformed into theE. coli strain BL-21 (DE3) (Section
2.1.8); this strain has been extensively used in protein overexpression due to its absence
of proteases. Scplp was cloned downstream of the p-Gal promoter and IPTG was used to
inhibit the suppression of this promoter and as a result drive protein synthesis. Fig. 3.1a
shows protein samples from before and after induction with a band of around 22 kDa
.being heavily stained after induction, the presence of this band in the pre- induction 
sample is due to leakage through the p-Gal promoter.
After the cells had been lysed the Scplp was found as an insoluble protein (Fig. 3.1b) 
aggregated in inclusion bodies; these were then isolated from the other cellular material 
by a series of washes (Fig. 3.1b) (Section 2.2,2), before suspending in urea for fiirther 
purification.
3.1,2 Purification of Scplp: ion exchange chromatography
In order to purify Scplp from the other proteins in the inclusion bodies it was necessary 
to use various column chromatography techniques. In the first instance it was decided to 
use ion exchange chromatography (Section 2.2.3); this separates proteins using their 
affinity to bind to either a positive or negative charged resin. Scplp has a predicted pi of
9.5 and therefore would be expected to bind to a cation exchanger resin at pH values near 
neutrality.
The weak cation exchanger CM-Sepharose-CL6B had previously been used in the 
purification of calponin (Winder and Walsh, 1990) and this proved an effective first step 
in the purification of Scplp. It readily bound to the resin with displacement occurring at 
salt concentrations of I
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Fig 3.1. Expression of Scplp and isolation of Scplp-rich inclusion 
bodies: (A) Protein samples were taken from BL-21 E. coli containing pSJW 
1-SCPlboth before (u); and after (i) induction and separated on a 12.5% 
poly-acrylamide gel, a band o f -22  kDa corresponding to Scplp can be seen 
to increase in intensity after induction (B) Scplp is absent in the soluble 
fraction of protein (s i) but is found in the pellet (pi) as inclusion bodies. 
Purification of these inclusion bodies was achieved by carrying out a series 
of wash/low speed centrifugation steps (2 -  10), with samples from each 
pellet (p) and supernatant (s) fractions analysed. Scplp containing inclusion 
bodies were then solubilised in 8 M urea (11) and then diluted down to 6 M 
urea ( 12) ready for purification.
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Fig. 3.2 Purification of Scplp by ion exchange chromatography
Scplp-containing inclusion bodies soloubilised in 6 M urea were loaded onto a 
CM-CL6B ion exchange column, and eluted using a 0-500 mM NaCl gradient. 
The blue bar indicates the fractions which were eluted at -200 mM NaCl and 
were analysed by SDS-PAGE. (B) Analysis o f fractions from ion exchange on 
SDS-PAGE shows a separation from some o f the contaminating bands. The red 
bar indicates the fractions which were considered to be the least contaminated 
by the high and low molecular mass species, and were then pooled together for 
further purification
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around 200 mM (Fig. 3.2a). Since more than one protein was present in the all of the 
fractions comprising the peak, it was necessary to select the ones which contained the 
fewest contaminants (Fig. 3.2b), for use in further purification steps.
3.1.3 Purification of Scplp: hydroxyapatite chromatography
Other purification methods which have been used on proteins of the Scplp family include 
gel filtration chromatography (Section 2.2.4); this was ruled out due to the presence of 
contaminating proteins close to the molecular mass of Scplp, and hydroxyapatite 
chromatography (section 2.2.5). Hydroxyapatite is a crystalline form of calcium 
phosphate [Ca5(P0 4 )3 0 H]2 which, because it contains both positively and negatively 
charged centres, can operate as a mixed ion-exchanger. Hydroxyapatite can be used in 
both batch and column modes, and is chemically and thermally stable with a low non- 
specific adsorption of hydrophobic macromolecules.Because elution is generally 
performed under mild conditions, hydroxyapatite chromatography generally gives good 
recoveries of proteins.
Scplp was found to bind to hydroxyapatite and elution occurred at a phosphate 
concentration of around 20mM (Fig. 3.3a). Although there were still small amounts of 
contaminating proteins present, some of the fractions were deemed to be pure enough 
(>95%) for further experimental purposes (Fig. 3.3b).
3,1.4 Refolding Scplp from urea
In order to carry out functional analysis of Scplp it was necessary to convert the protein 
to its native form, since the purification steps had been carried out on the protein in a 
denatured state in 6 M urea. Refolding of the Scplp involved a step-by-step dialysis from 
urea into a suitable buffer, which should allow folding to occur. The correct conditions 
were established by performing test experiments using buffers with a range of pH (6.0, 
6.5, 7.0, 7.5, 8.0, 8.5, & 9.0) and NaCl concentrations (0, 50, 100, 25, & 500 mM). The 
only conditions under which Scplp remained soluble during the dialysis from urea were 
pH 6.0 (this was achieved using 20 mM Mes pH 6.0) with 0 mM NaCl. Even under these
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Fig. 3.3 Purification of Scplp by hydroxyapatite chromatography
In (A) Scplp containing fractions pooled together from ion exchange 
chromatography were loaded onto a hydroxyapatite column, and eluted 
using a 1-100 mM KH2PO4 gradient; the blue bar indicates the fractions 
analysed by SDS-PAGE. (B) Analysis of fractions by SDS-PAGE shows a 
separation o f scplp from contaminating proteins; the red bar indicates the 
fractions considered to be the least contaminated by the high and low 
molecular mass species, which were then pooled together.
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conditions which allowed refolding, less than half of the total Scplp remained soluble 
after the complete removal of the urea. It should be noted that in order to concentrate 
Scplp after refolding, it was necessary to use a pressure-driven concentrator instead of 
the centrifugation type as use of the latter caused the Scplp to form a gel in the bottom of ' 
the concentrator tube.
I
3.1.5 CD Analysis of purified Scplp
Once purified Scplp had been obtained, it was necessary to establish that it was indeed 
correctly folded; this was done using the technique of Circular Dichroism (CD). CD 
exploits the fact that different secondary structural features in a protein posses chirality 
and these will absorb left and right circularly polarised components of polarised light 
differentially. The resultant trace (Fig. 3.4) in the far UV region where the peptide bonds 
absorbs can then be analysed using various published programs to estimate the secondary 
stmcture composition o f a protein. Previous investigations on proteins containing single 
CH Domains have shown them to posses a significant amount of a-helix and Scplp 
appears to fit this pattern with a predicted secondary structure consisting o f-  23 % a - 
helix, 19 % anti-parallel sheet, 4 % parallel sheet, 21 % turns, and 33 % other structures.
It was also found that pH had a marked effect on the stability o f the purified Scplp with a 
shift fi-om pH 6.0 to pH 8.0 resulting in a greater degree of unfolding of the protein than 
was obtained with 4 M urea (Fig. 3.4).
3.2 Actin-binding properties of Scplp
3.2.1 Characteristics of Scplp binding to actin
In order to determine whether the purified Scplp could bind to actin, a high-speed 
sedimentation assay (100000 g) was performed (Section 2.3.3), The result fi*om this (Fig. 
3.5a) shows that the Scplp alone is present in the supernatant fi'action and migrates to the
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Fig. 3.4 Far UV CD spectra of Scplp
CD measurements were performed on a 0.5 mgml * Scplp solution 
comtaining:- 20 mM Mes pH 6.0, 1 mM EGTA (blue); 20 mM Mes pH 6,0, 1 
mM EGTA, 2 M GdnCl (green); 20 mM Mes pH 6.0, 1 mM EGTA, 4 M 
GdnCl (red); 10 mM Tris pH 8.0, 1 mM EGTA, (aqua), using a cell with a 0.02 
cm pathlength.
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Fig. 3.5 Sedimentation assay for actin binding
(A.) Increasing concentrations of Scplp, from 0.1 to 5 pM were incubated 
with 5 |iM F-actin and subjected to high speed ultracentrifugation. Scplp is 
seen to co-sediment with actin in the pellet (P) whereas Scplp alone remains 
in the supernatant (S) (B) F-actin was subjected to low-speed sedimentation 
after polymerisation in the prescence o f increasing concentrations o f Scplp. 
In the abscence of Scplp most o f the actin is found in the supernatant, 
however after addition o f at least O.l |iM Scplp more actin co-sedimented in 
the pellet with Scplpl.
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Pellet fraction when mixed with F-actin, indicating its ability to bind to actin. Calponin 
and SM22, proteins which are both homologous to Scplp have been shown to induce the 
formation of parallel bundles of actin filaments (bundling) or cross-link actin filaments 
into mesh-like structures (gelling) (Kolakowski et al 1995, Shapland et al 1993) and 
therefore it was predicted that Scplp might have a similar activity. To investigate this, a 
low speed sedimentation assay was performed (Section 2.3.2); the slower centrifiigation 
(13000 g) pellets actin bundles whilst leaving unbundled F-actin in the supernatatant. The 
experiment shows (Fig. 3.5b) that with increasing concentrations of Scplp, there is a 
clear shift in the actin from the supernatant to the pellet fraction.
The different effects that actin-binding proteins can have on F-actin can also be 
monitored using a falling ball viscosity assay (Section 2.3.1), which exploits the change 
in viscosity of a solution of G-actin as it is polymerised to F-actin. A further change in 
viscosity occurs when F-actin is either cross-linked, bundled or severed. Since the results 
of the low speed sedimentation assay pointed to a role for Scplp in bundling actin 
filaments, it was expected that an increase in viscosity would occur as a meshwork of 
actin bundles was created. Surprisingly, when Scplp was added to 5 pM actin in this 
assay a decrease in the viscosity was observed (Fig. 3.6), with a >95 % decrease in #
viscosity occurring at as little as IpM  Scplp. Although the viscosity results appeared to 
contradict the sedimentation data it should be noted that other bundling proteins such as 
Scruin (Owen et al 1993, Schmid et al 1994) exhibited the same characteristics. The 
observations could be explained by Scplp inducing the formation of very tight parallel 
bundles, which could then be easily displaced by the ball bearing in the viscosity assay.
In order to visualise the F-actin structure, Scplp was added to actin and polymerised 
before being negatively stained and viewed by electron microscopy (Fig. 3.7) (Section 
2.3.4). It can be seen from Fig. 3.7b that Scplp does indeed cause the formation of tight 
actin bundles as they are absent from Fig. 3.7a which shows actin alone.
3.2.2 The effect of Scplp on the kinetics of actin polymerisation/ depolymerisation
The kinetics of actin polymerisation/depolymerisation have been widely used to 
characterise actin-binding proteins. This technique exploits the change in fluorescence of 
pyrene-labelled G-actin as it is converted to F-actin. Scplp was added to a solution of
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Fig. 3.6 Falling ball assay viscosity assay
Failing -ball assays were performed to investigate the effect of Scplp on 
the viscosity o f an F-actin solution. Increasing concentrations o f Scplp 
resulted in a decrease in viscosity o f the solution, indicating either a 
severing or very tight bundling activity.
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Fig. 3.7 Electron microscopy af actin and Scplp
Actin filaments were polymerised in the absence (A) or prescence (B) o f 1 
pM Scplp for 3 h. Filaments were negatively stained with Nanovan 
(Section 2.3.4) and visualised using a Zeiss 902 electron microscope. The 
scale bars represent 200 nm Arrows indicate Scplp-induced actin bundles.
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Fig. 3.8 Effects of S cp lp  on polymerisation/depolymerisation kinetics of 
pyrenyl-actin: 1 fiM pyrene-actin was polymerised in the absence (black line, 
circles on inset)or presence (grey lines , squares on inset) o f Scplp (0.5 pM) 
and the resulting fluorescence measured over 1000 s (panel A). There was no 
apparent difference between these two samples except for a slight reduction in 
the lag phase, which is further illustrated in the expanded view which covers 
the first 40 s (inset box). Depolymerisation kinetics (panel B) o f pyrene-actin 
plus Scpl (grey line) were also slightly retarded compared with those o f 
pyrene-actin alone (black line). There was no change in the steady state 
kinetics o f pyrene-actin turnover (panel B inset) in those samples containing 
pyrene-actin plus Scplp (grey line), compared with those containing pyrene- 
actin on its own (black line).
I
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pyrene-actin and polymerised (Section 2.3.5). As shown in Fig. 3.8 there was no effect on 
the rate o f polymerisation except for a slight reduction in the lag phase; this can be 
ascribed to the stabilisation of short filaments due to bundling. A slight inhibition of 
depolymerisation could also be observed which is also common amongst actin-bundling 
proteins reflecting the increased stability of the F-actin.
3.2.3 The regions of Scplp which are responsible for actin-binding and bundling 
activity
It has been previously reported that the actin-binding domain o f calponin does not 
include the amino terminal CH domain but starts on its C-terminal portion and includes 
the first calponin-like repeat (CLR) (Gimona, 1998), In order to determine whether this 
was also the case for Scplp, a 6 kDa fragment was generated by limited proteolysis of the 
full length protein and used in a high speed sedimentation assay (Section 2.3.3). As 
shown in Fig. 3.9, a 6 kDa band is found in the supernatant in the absence of actin, which 
shifts to the pellet as it is added to actin . Mass spectrometry (MS) of this fragment 
yeilded a major species with mass of 6297 Da, which was predicted to correspond to 
residues 139-195 of Scplp. Internal sequencing of this fragment carried out by MS 
yielded the sequence YGYMKGASQATEGVVLGQ corresponding to residues 177-194 
of Scplp and confirming its identity as the C-terminal 60 residues of Scplp including the 
CLR but excluding the CH-domain.
To define in more detail the regions of Scplp which are responsible for actin binding, it 
is necessary to generate truncation mutants. To generate N- and C-terminal fragments, 
forward and reverse primers were designed complementary to the coding sequences of 
the N-terminal (amino acids 1-142), and C-terminal (amino acids 142-200) parts of Scpl, 
and were engineered to have EcoRl and Xhol restriction sites in the forward and reverse 
primers to allow further sub-cloning. The PCR-amplified fragments of the predicted size 
(ie.400 bp for the N-terminal mutant and 200 bp for the C-terminal) mutant were then 
ligated into the EcoRl/Xhol sites of the expression vector PGEX-4T (Fig. 3.10). A third 
cDNA corresponding to full length Scpl (amino acids 1-200) was also cloned into this 
vector using this strategy (Fig.3.10c discussed later in Section 3.3.3). Clones were 
sequenced to check for enors and expression o f the mutant protein tested (Fig. 3.11).
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Fig. 3.9 Analysis of proteolytic fragment of Sep Ip reveals an actin- 
binding region: Proteolytic fragments of Sop Ip (5 pM) were subjected to 
ultracentrifugation, after incubation in the absence (lanes 1), or presence 
(lanes2) o f actin (5 pM). After analysis by SDS-PAGE using a 7.5-20 % , a 
6 kDa band; corresponding to the C-terminal region of Sep Ip, can be seen 
to shift from the supernatant (S) fraction to the pellet (P) fraction with actin.
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Fig. 3.10 Restriction analysis pGEX-4T clones, containing SCPl 
fragments: (A)The CH domain o f SCPl was cloned into pGEX-4T, and 
checked by an EcoRl/Xhol restriction digest, before being separated on a 1 
% agarose gel. The presence o f a band o f -400 bp, corresponding to the CH 
domain o f SCPl can be seen in both clones 2 and 3. (B)The CLR of SCPl 
was cloned into pGEX-4T, and checked by an EcoRl/Xhol restriction 
digest. The presence o f a band o f -200 bp, corresponding to the CLR of  
SCPl can be seen in both clones 2 and 3. (C)Full length SCPl was cloned 
into pGEX-4T, and checked by an EcoRl/Xhol restriction digest. The 
presence of a band o f -600 bp, corresponding to full length SCPl can be 
seen in both clones 2 and 3.
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Fig. 3.11 Expression of Scplp and its N-and C-terminal mutants 
expressed as GST-fusion proteins.: BL-21 (DE3) E.coli were transformed 
with pGEX-4T N-term SCPl (lanes 1-4); pGEX-4T SCP (lanes 5 and 6); 
pGEX-4T (lanes 7 and 8); and pGEX-4T C-term SCPl (lanes 9-12). Cells 
containing these plasmids were then grown to mid log phase, before 
expression was induced, and a sample removed before (lanes 1,3,5,  7, 9, 11); 
and after (lanes 2, 4, 6, 8, 10, 12) induction. Samples were then analysed by 
SDS-PAGE on a 12.5 % gel.
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Purification of the mutants and full length GST-fosion protein was carried out according 
to the manufacturers recommendations (section 2,2,10); however the C-term-GST fusion 
did not express a soluble protein (data not shown) and so a different strategy was 
adopted. The C-terminal CLR region was amplified from pSJW l-Scplp using primers 
containing engineered Ndel and Xhol restriction sites which would allow cloning into a 
pET-14B vector at the appropriate sites to generate a 6xHis-tagged over-expressed 
protein. This was then purified according to the manufacturers recommendations (section 
2.2.10)-9+. High speed sedimentation assays (section 2.3.3) with the soluble Scplp 
mutant proteins (Fig. 3.12) shows that a significant proportion of the C-terminal His- 
tagged mutant is present in the pellet fraction, indicating a role for the CLR of Scplp in 
actin binding. The GST-N-term mutant does not co-sediment with actin in this assay, 
consistent with previous work showing that CH domains are not sufficient on their own 
to bind actin (Gimona & Winder 1998).
3.3 In vivo studies of the role of Scplp in S, cerevisiae
3.3.1 Co-localisation of Scplp with actin
In order to understand the role that of Scplp within the cell in more detail an antibody 
was raised against the protein after purification on SDS -  PAGE (section 2.2.6). 
Following affinity purification (section 2.2.9) the antibody was able to cross-react with a 
protein of mass around 20 kDa, corresponding to Scplp, in yeast whole cell lysates (Fig
3.13).
This antibody was then used in immunofluorescence microscopy (section 2.4.2), to 
examine the intracellular localisation of Scplp within the yeast cell, and in particular 
whether it is co-localised with actin. However, despite using a variety of fixation 
techniques and processing procedures no specific staining for scplp could be detected. 
Since the biochemical evidence (section 3.2) points to a role for Scplp in the formation 
of tight actin bundles, the lack of detection by the antibody could arise from a blocking of 
the epitopes on the protein due to its presence within the actin bundles.
"I
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Fig. 3.12 Actin-binding properties of Scplp fragments.
6xHis-taggedC-term Scplp (25 pM lanes land 2) or, GST N-term scplp 
(10 pM lanes 3 and 4) was incubated in the absence (lanes 1 and 3), or 
presence (lanes 2 and 4) o f actin (5 pM) and subjected to ultrcentrifugation 
followed by analysis by SDS-PAGE on a 15 % gel A significant amount 
of the 6xHis-taggedC-term Scplp can be seen to shift from the supernatant 
to the pellet fraction in the prescence of actin, whereas there was no 
change in the distribution o f GST N-term scplp. Proteins o f interest are 
labelled, with the remaining bands consisting o f a co-purifying yeast 
protein (lanes 1-4), and a degradation product (lanes 3 and 4).
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Fig. 3.13 Immumoblottinng of Scplp
Western blot analysis using an affinity purified anti-Scplp rabbit polyclonal 
antibody detects a band o f -22  kDa in a wild type yeast, whole cell lysate 
(lane 1) which runs parallel to purified Scplp (lane 2). There was some 
degradation o f the purified Scplp, resulting in the presence of a lower band 
in lane 2.
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In order to visualise the intracellular location of Scplp it was tagged with Green 
Fluorescent Protein GFP at its N-terminus (Winder, Jess, & Ayscough 2003). 
Immunofluorescence experiments using GFP-Scplp along with rhodamine-phalloidin 
staining revealed a co-localisation of Scplp with actin patches at the cell cortex (Fig.
3.14). This co-localisation of Scplp to cortical actin patches can also be seen to be 
disrupted in cells expressing GFP-Scplp which were exposed to the actin monomer- 
sequestering drug latrunculin-A; this is consistent with Scplp having a role in the 
formation or stabilisation of cortical actin patches (Winder, Jess, & Ayscough 2003).
3.3.2. Effect of deletion of SCPl gene
In the first instance it was decided to look at the effects of deleting the SCPl gene from S. 
cerevisiae since deletion studies in yeast have proved to be a powerful tool in helping to 
determine the in vivo role of actin-binding proteins (Adams, Botstein, & Drubin 1991); in 
addition gene-deleted strains are commercially available.
Microscopy using rhodamine-phalloidin (section 2.4.1) to visualise actin failed to show 
any differences in the organisation of the actin cyto skeleton between the SCPl-null and 
the wild type strains, with both actin cables and cortical actin patches being clearly 
visible and highly polarised at various points in the cell cycle (Fig. 3.15).
The failure of SCPl deletion to have any effect on the actin cytoskeleton arrangement is 
indicative of an overlapping function with another gene. In order to characterise further 
the role of Scplp in vivo, it was decided to examine the possible involvement of 2 other 
proteins, namely:- (a) Sac6p, the yeast homologue of fimbrin , the only other protein 
found to date shown to have a major role in actin bundling and filament stabilsation 
(Adams, Botstein, & Drubin 1989; Adams, Botstein, & Drubin 1991), and (b) Cap2p, an 
actin-capping protein, since deletion o f both the CAP2 and SAC6 has been shown to be 
synthetically lethal (Adams, Cooper, & Drubin 1993). SCPl-null yeast cells were crossed 
with cells disrupted in either the SAC6 or CAP 2 gene to check for synthetic lethality 
(Section 2.6.2 and 2.6.3). Cells containing both sets of deletion were found to be viable 
(Fig. 3.16a). However it was found that cells with the Ascpl Asac6 genotype had an 
aberrant actin phenotype with only 2 % of them containing polarised cortical actin
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Fig. 3.14 Co-localisation of actin with Scplp in S. cerevisiae 
GFP-Scplp expressing yeast cells were fixed and stained with rhodamine 
phalloidin to visualize actin. In panel A, GFP-Scplp is seen to be present 
in small punctate patches at the cell cortex where it appears to co-localise 
with actin, shown in panel B stained with rhodamine phalloidin. Scale 
bars, 5 pm.
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Fig 3.15 Effect of deletion of SCPl gene on the organization of actin
in A, cerevisiae;Yeast cells in which SCPl had been deleted (KAY446) 
displayed no aberrant actin phenotype compared to that o f wild type cells 
(KAY448) when viewed after fixation and staining with rhodamine- 
phalloidin.
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Fig. 3.16 Effects of deletion of SCPl, SAC6 and CAP2 genes in S. 
cerevisiae. (A) Yeast cells deleted for SCPl were crossed with either cells 
deleted for SAC6 (panel 1) or CAP2 (panel 2) and tetrads separated from the 
resulting four-spored asci. These were plated out onto YPAD and left to 
germinate. In both panels each o f the 4 spores from the tetrad produced 
viable colonies, indicating absence o f any synthetic lethality between SCPl 
and either SAC6 or CAP2. (B) Each o f the four genetic variants from the 
cross between ASCPl and ASAC6, were allowed to germinate and grow. 
After fixing, cells were stained with rhodamine-phalloidin to visualise the 
actin structures within Cells with the single SCPl deletion have only minor 
defects in their actin cytoskeleton when compared to cells containing both 
genes, with ASAC6 and ASCP1/ASAC6 (panel 4) displaying an increasingly 
disrupted actin cytoskeleton. Scale bars, 5 pm.
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patches compared with 88 % in the Ascpl cells and 90 % of wild type (Fig. 3 .16b). Later 
experiments showed that the Ascpl Asac6 double mutant is more sensitive to latrunculin- 
A than either the Ascpl or the Asac6 mutants alone (Winder, Jess, & Ayscough 2003). 
These results suggest a role for both Scplp and Sac6p acting together in organising the 
yeast F-actin cytoskeleton.
3.3.3 Effect of over-expression of SCP gene
With the Scplp deletion mutants showing no real phenotype unless present in a SAC6 
null background (Section 3.3.2) it was decided to examine whether over-expression of the 
SCPl gene would have any effect on the actin cytoskeleton, since this has also been the 
case for the actin binding protein ABPl, which when deleted shows no phenotype but 
leads to an aberrant actin phenotype when over-expressed (Drubin, Miller, & Botstein 
1988). In order to achieve this, SCPl cDNA was cloned downstream of the inducible 
methionine promoter (sections 2.1 and 3.2.3) in both the CEN plasmid which will 
produce 2 copies of the protein or the high copy number 2-pm plasmid (Fig. 3.10c), and 
then transformed into wild type yeast cells.
Over-expression from both of these plasmids resulted in lethality when grown on agar 
plates (Fig. 3.17). In order to assess in more detail possible causes of this lethality the 
SCPl gene was over-expressed for shorter period in cells in liquid media, and the cells 
were then stained with rhodamine -phalloidin in order to visualise the actin structures 
(section 2.4.1). The results of this experiment (Fig. 3.18) show a clear time-dependent 
disruption of both actin patches and cables. Within 4 h there was a clumping of actin 
patches at the site of bud formation; however after 20 h where the aberrant clumps of 
actin could still be visualised, the cells appeared smaller and un-budded.
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Fig. 3.17 Effects of overexpression of SCPl gene in S. cerevisiae 
Yeast cells containing a SCPl gene under the control o f an inducible 
methionine promoters on either the CEN; 2 copy or 2 pm; multiple copy 
plasmid, were plated onto synthetic media lacking uracil (d o. URA) (necessary 
to maintain the plasmid within the cell). Scplp overexpression was induced by 
plating the cells on to synthetic media lacking uracil and methionine (d o. URA, 
MET), alongside cell containing only the methionine promoter. Overexpession 
from either the CEN or the 2 pm plasmid resulted in an almost complete lack o f  
growth, whereas the cell containing just the methionine promoter appeared to 
grow normally.
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pMET SCPl uninduced
pMET SCPl induced
Fig. 3.18 EfTect of over expression of the SCPl gene on S. cerevisiae 
grown in liquid media: Cells containing the plasmid responsible for 
overexpression o f the SCPl gene were grown in the presence (top) and 
absence (bottom) of methionine. Both sets of cells were fixed and stained 
with rhodamine -phalloidin to detect actin, which can be seen to form both 
actin patches and cables in the the uninduced cells, compared to the large 
aggregates of actin which can be seen in cells induced to overexpress Scplp. 
Scale bars 5 pm.
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4 Discussion
In this study it has been shown that in vitro Scplp, a member of the calponin,
SM22/transgelin family of proteins both binds to actin and induces the formation of tight
actin bundles. Furthermore it has been shown that the carboxy terminal region of Scplp
.including the CLR and the preceding sequence (but excluding the CH domain) is 
sufficient to bind actin. The role of Scplp in vivo and has also been investigated and it 
has been shown that Scplp localises to actin structures within the cell and acts with other 
actin-binding proteins to regulate actin dynamics.
Biochemical analysis using high and low-speed sedimentation assays together with 
viscosity assays has shown that Scplp binds to actin with a Kd o f -0.5 pM, a figure 
similar to that reported for calponin which binds actin with a Kd o f 1 pM (Lu, Freedman, 
& Chalovich 1995). Calponin and SM22/transgelin have also been reported to induce the 
formation of organised actin networks (Kolakowski et al. 1995;Shapland et al. 1993); 
here it has been shown by EM that Scplp is able to organise actin filaments into tight 
bundles. At first sight this finding would appear to be at odds with the falling ball data 
which showed a decrease in the viscosity of a solution of F-actin, indicating that Scplp 
was involved in severing o f actin filaments. This apparent contradiction has also been 
reported in proteins such as scruin (Owen & DeRosier 1993;Sanders et al. 1996); and can 
be explained by the formation of very tight parallel bundles which can be easily displaced 
to create a free channel for the falling ball. The kinetics of polymerisation of actin in the 
presence of Scplp also suggests that Scplp can stabilise very short filaments of actin.
In order for a protein to able to bundle actin it requires either two actin-binding sites 
within a single polypeptide or the ablity to dimerise to form two actin-binding sites. 
Purified Scplp was subjected to analytical gel-filtration, and assessed to be monomeric, a 
finding also reported for calponin and SM22/transgelin (S hap land, Hsuan, Totty, & 
Lawson 1993). It has previously been shown that CH domains are not sufficient or 
necessary to bind actin but may seiwe to
SM22/transgelin have reported two putative actin-binding sites located in the CLR and
the region between it and the CH domain. In the present work a 6 kDa fragment of Scplp
corresponding to the region C-terminal of the CH domain including the CLR has been
identified, and shown to be sufficient to bundle actin in a low-speed sedimentation assay.
Calponin family members contain a conserved serine in the first CLR (Ser^^  ^in calponin,
Ser^^  ^in SM22/transgelin), which has been shown to be critical for actin binding (Fu et
al. 2000;Winder et al. 1993). Since Scplp also contains this conserved residue (Ser^^^) it
is likely to function in a similar fashion. A second actin-binding site must therefore reside
. .in the region between the CH domain and the CLR. In a similar manner to ABSlin 
calponin (EL Mezgueldi et al. 1996) this site consists o f a stretch of basic amino acids, 
which could act as a poly-cation that is able to interact with acidic actin filaments. Some 
doubt has been raised over the validity of the reports concerning the actin-bundling 
activity o f SM22/transgeIin (Morgan & Gangopadhyay 2001). Since bundling only 
occurs at low ionic strengths it is possible that it could be due to non-specific electrostatic 
interactions. In order to rule out this possibility all experiments on the properties of actin 
binding by Scplp were carried out at a physiological salt concentration.
Using a S. cerevisiae strain from which the SCPl gene had been deleted no aberrant actin 
phenotype could be observed, indicating that Scplp may have a shared function with 
another protein.The fimbrin homologue Sac6p has previously been shown to localise to 
actin patches in vivo, and has been implicated in the regulation o f actin dynamics 
(Drubin, Miller, & Botstein 1988). In this work it has been shown that GFP-Scplp also 
localises to actin patches and the relationship between these two proteins and the actin 
cytoskeleton has been investigated. Deletion of SAC6 and SCPl resulted in a strain 
which, although viable, had a phenotype more severe than either deletion alone. Further 
analysis of gene-deleted strains has revealed a sensitivity to the G-actin monomer- 
sequestering drug Latrunculin A in both ASCPl and ASAC6 knockouts and an increased 
sensitivity in a ASCP1/ASAC6 double knockout (Winder, Jess, & Ayscough 2003). These 
effects are thought to result from a decrease in the stability of actin filaments leading to 
an increase in G-actin turnover. It has also shown that overexpression o f SCPl causes the 
formation of aberrant actin structures, presumably as a consequence o f a more stabilised 
actin cytoskeleton and a decrease in actin dynamics.
A report by Goodman et al, published at the same time as this work was completed, has 
also shown that Scplp is an actin-binding protein with the ability to cross-link actin 
filaments into larger networks (Goodman et al. 2003), Their biochemical and genetic
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analysis of Scplp truncation mutants has validated the results in this Thesis concerning 
the location of the actin-binding sites and have also shown that Ser^^  ^is indeed critical 
for actin binding. Goodman et al. have also shown localisation o f Scplp to actin patches 
in S. cerevisiae and have reported a functional relationship between Scplp and the 
fimbrin homologue Sac6p in the control of the actin cytoskeleton.
More recently Scplp has been implicated as being involved in the regulation of the actin 
cytoskeleton and playing a role in cell ageing (Gourlay et al. 2004). AScplp strains were 
shown to be viable for longer than wild type yeast, and strains overexpressing Scplp 
exhibited a reduction in the length of time cells were viable and an increased level of 
reactive oxygen species ROS in the cell. These findings suggest a link between the 
stability of actin filaments and mitochondrial integrity in regulating cell death.
Further work is necessary to characterise fully the regions of Scplp which interact with 
actin, and is likely to include engineering a larger panel of mutant proteins, with 
emphasis on the regions between the CH domain and the CLR/CLIK23 repeat, and the 
residues surrounding Ser^^ .^ Further work with genetically modified S. cerevisiae strains 
is required to understand more completely the role of Scplp in vivo and further 
characterise its relationship with Sac6p in the organisation of the actin cytoskeleton.
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